WO2000004192A1 - Methods for detecting and mapping genes, mutations and variant polynucleotide sequences - Google Patents
Methods for detecting and mapping genes, mutations and variant polynucleotide sequences Download PDFInfo
- Publication number
- WO2000004192A1 WO2000004192A1 PCT/US1999/016242 US9916242W WO0004192A1 WO 2000004192 A1 WO2000004192 A1 WO 2000004192A1 US 9916242 W US9916242 W US 9916242W WO 0004192 A1 WO0004192 A1 WO 0004192A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- probe
- linker
- reporter
- gene
- tag
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 246
- 108091033319 polynucleotide Proteins 0.000 title claims description 207
- 102000040430 polynucleotide Human genes 0.000 title claims description 207
- 239000002157 polynucleotide Substances 0.000 title claims description 207
- 108090000623 proteins and genes Proteins 0.000 title abstract description 28
- 230000035772 mutation Effects 0.000 title description 17
- 238000013507 mapping Methods 0.000 title description 6
- 239000000523 sample Substances 0.000 claims abstract description 874
- 230000000295 complement effect Effects 0.000 claims abstract description 143
- 238000009396 hybridization Methods 0.000 claims abstract description 122
- 238000002372 labelling Methods 0.000 claims abstract description 56
- 230000027455 binding Effects 0.000 claims abstract description 38
- 239000002131 composite material Substances 0.000 claims abstract description 32
- 238000003491 array Methods 0.000 claims abstract description 26
- 238000009482 thermal adhesion granulation Methods 0.000 claims description 533
- 238000005304 joining Methods 0.000 claims description 102
- 230000000692 anti-sense effect Effects 0.000 claims description 85
- 108020004414 DNA Proteins 0.000 claims description 83
- 125000003729 nucleotide group Chemical group 0.000 claims description 83
- 108091034117 Oligonucleotide Proteins 0.000 claims description 82
- 239000002773 nucleotide Substances 0.000 claims description 82
- 125000006850 spacer group Chemical group 0.000 claims description 62
- 241000555293 Bassariscus astutus Species 0.000 claims description 50
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 50
- 238000001514 detection method Methods 0.000 claims description 50
- 108091027568 Single-stranded nucleotide Proteins 0.000 claims description 40
- 239000000203 mixture Substances 0.000 claims description 38
- 238000004132 cross linking Methods 0.000 claims description 27
- 108091081021 Sense strand Proteins 0.000 claims description 24
- 150000007523 nucleic acids Chemical group 0.000 claims description 22
- 230000003321 amplification Effects 0.000 claims description 18
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 239000003086 colorant Substances 0.000 claims description 16
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 13
- 238000005406 washing Methods 0.000 claims description 13
- 230000000694 effects Effects 0.000 claims description 12
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 12
- 108020004635 Complementary DNA Proteins 0.000 claims description 11
- 102000053602 DNA Human genes 0.000 claims description 11
- 229910052737 gold Inorganic materials 0.000 claims description 11
- 239000010931 gold Substances 0.000 claims description 11
- 238000012408 PCR amplification Methods 0.000 claims description 10
- 229910052709 silver Inorganic materials 0.000 claims description 10
- 239000004332 silver Substances 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 9
- 108020004711 Nucleic Acid Probes Proteins 0.000 claims description 8
- 239000002853 nucleic acid probe Substances 0.000 claims description 8
- 238000009877 rendering Methods 0.000 claims description 8
- 239000002787 antisense oligonuctleotide Substances 0.000 claims description 6
- 230000000063 preceeding effect Effects 0.000 claims description 2
- 230000011664 signaling Effects 0.000 abstract description 55
- 238000013461 design Methods 0.000 abstract description 33
- 239000012528 membrane Substances 0.000 abstract description 16
- 238000011065 in-situ storage Methods 0.000 abstract description 8
- 239000007787 solid Substances 0.000 abstract description 4
- 239000000758 substrate Substances 0.000 abstract description 4
- 125000005647 linker group Chemical group 0.000 description 324
- 238000003752 polymerase chain reaction Methods 0.000 description 50
- 239000002585 base Substances 0.000 description 47
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 47
- 230000002441 reversible effect Effects 0.000 description 28
- 238000002509 fluorescent in situ hybridization Methods 0.000 description 26
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 25
- 108010000239 Aequorin Proteins 0.000 description 22
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 22
- 239000000370 acceptor Substances 0.000 description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 229910052799 carbon Inorganic materials 0.000 description 18
- 239000010410 layer Substances 0.000 description 18
- 230000009977 dual effect Effects 0.000 description 17
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 16
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 15
- 239000002751 oligonucleotide probe Substances 0.000 description 15
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 14
- 238000012986 modification Methods 0.000 description 14
- 230000004048 modification Effects 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 238000011160 research Methods 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 12
- 210000000349 chromosome Anatomy 0.000 description 12
- 238000010276 construction Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 102000039446 nucleic acids Human genes 0.000 description 11
- 108020004707 nucleic acids Proteins 0.000 description 11
- -1 psoralen compound Chemical class 0.000 description 11
- 230000008901 benefit Effects 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 238000005516 engineering process Methods 0.000 description 10
- 238000002156 mixing Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 9
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 8
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 8
- 239000004677 Nylon Substances 0.000 description 8
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 8
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 239000000412 dendrimer Substances 0.000 description 8
- 229920000736 dendritic polymer Polymers 0.000 description 8
- 229920001778 nylon Polymers 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 229940104230 thymidine Drugs 0.000 description 8
- FMHHVULEAZTJMA-UHFFFAOYSA-N trioxsalen Chemical compound CC1=CC(=O)OC2=C1C=C1C=C(C)OC1=C2C FMHHVULEAZTJMA-UHFFFAOYSA-N 0.000 description 8
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 7
- 238000000137 annealing Methods 0.000 description 7
- 229960002685 biotin Drugs 0.000 description 7
- 235000020958 biotin Nutrition 0.000 description 7
- 239000011616 biotin Substances 0.000 description 7
- 239000003298 DNA probe Substances 0.000 description 6
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 6
- 238000004925 denaturation Methods 0.000 description 6
- 230000036425 denaturation Effects 0.000 description 6
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 6
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 6
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 150000008300 phosphoramidites Chemical class 0.000 description 6
- 230000008685 targeting Effects 0.000 description 6
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 5
- 108010061982 DNA Ligases Proteins 0.000 description 5
- 102000012410 DNA Ligases Human genes 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- SFYISUPIFOZKLQ-CXAGYDPISA-N n-[(2r,3r)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-(2-phenylethynyl)benzamide Chemical compound C1=CC(C(=O)N[C@H]([C@H](O)C)C(=O)NO)=CC=C1C#CC1=CC=CC=C1 SFYISUPIFOZKLQ-CXAGYDPISA-N 0.000 description 5
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- 108020004465 16S ribosomal RNA Proteins 0.000 description 4
- 108090001008 Avidin Proteins 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical class O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 4
- 102000003960 Ligases Human genes 0.000 description 4
- 108090000364 Ligases Proteins 0.000 description 4
- 238000001069 Raman spectroscopy Methods 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 230000031864 metaphase Effects 0.000 description 4
- 238000002493 microarray Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000003252 repetitive effect Effects 0.000 description 4
- 238000011896 sensitive detection Methods 0.000 description 4
- 101150075835 Abr gene Proteins 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108010073466 Bombesin Receptors Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 230000016507 interphase Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 125000003396 thiol group Chemical class [H]S* 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- MJKVTPMWOKAVMS-UHFFFAOYSA-N 3-hydroxy-1-benzopyran-2-one Chemical compound C1=CC=C2OC(=O)C(O)=CC2=C1 MJKVTPMWOKAVMS-UHFFFAOYSA-N 0.000 description 2
- LUCHPKXVUGJYGU-UHFFFAOYSA-N 4-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-2-one Chemical compound O=C1N=C(N)C(C)=CN1C1OC(CO)C(O)C1 LUCHPKXVUGJYGU-UHFFFAOYSA-N 0.000 description 2
- 108091093088 Amplicon Proteins 0.000 description 2
- 108010092776 Autophagy-Related Protein 5 Proteins 0.000 description 2
- 102000016614 Autophagy-Related Protein 5 Human genes 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241001227713 Chiron Species 0.000 description 2
- 230000004544 DNA amplification Effects 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 2
- 102100029764 DNA-directed DNA/RNA polymerase mu Human genes 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 2
- 108091092878 Microsatellite Proteins 0.000 description 2
- 101710163270 Nuclease Proteins 0.000 description 2
- YHIPILPTUVMWQT-UHFFFAOYSA-N Oplophorus luciferin Chemical compound C1=CC(O)=CC=C1CC(C(N1C=C(N2)C=3C=CC(O)=CC=3)=O)=NC1=C2CC1=CC=CC=C1 YHIPILPTUVMWQT-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000001745 anti-biotin effect Effects 0.000 description 2
- 229910000266 aqualite Inorganic materials 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000029918 bioluminescence Effects 0.000 description 2
- 238000005415 bioluminescence Methods 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000019800 disodium phosphate Nutrition 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 210000003917 human chromosome Anatomy 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000007901 in situ hybridization Methods 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000012678 infectious agent Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- 238000002515 oligonucleotide synthesis Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
- 238000000163 radioactive labelling Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- SATOZHHJULWRHN-PJKMHFRUSA-N 1-[(2s,4s,5r)-2-amino-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical group O=C1NC(=O)C(C)=CN1[C@]1(N)O[C@H](CO)[C@@H](O)C1 SATOZHHJULWRHN-PJKMHFRUSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 1
- UMLFTCYAQPPZER-UHFFFAOYSA-N 4-(bromomethyl)benzonitrile Chemical compound BrCC1=CC=C(C#N)C=C1 UMLFTCYAQPPZER-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108010063905 Ampligase Proteins 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- RENMDAKOXSCIGH-UHFFFAOYSA-N Chloroacetonitrile Chemical compound ClCC#N RENMDAKOXSCIGH-UHFFFAOYSA-N 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 101710172390 DNA ligase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 244000046038 Ehretia acuminata Species 0.000 description 1
- 235000009300 Ehretia acuminata Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- LUWJPTVQOMUZLW-UHFFFAOYSA-N Luxol fast blue MBS Chemical compound [Cu++].Cc1ccccc1N\C(N)=N\c1ccccc1C.Cc1ccccc1N\C(N)=N\c1ccccc1C.OS(=O)(=O)c1cccc2c3nc(nc4nc([n-]c5[n-]c(nc6nc(n3)c3ccccc63)c3c(cccc53)S(O)(=O)=O)c3ccccc43)c12 LUWJPTVQOMUZLW-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000186367 Mycobacterium avium Species 0.000 description 1
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- HOZQTTSVDJPOOK-UHFFFAOYSA-N P([O-])([O-])N.[C+4].P([O-])([O-])N Chemical compound P([O-])([O-])N.[C+4].P([O-])([O-])N HOZQTTSVDJPOOK-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 108091008109 Pseudogenes Proteins 0.000 description 1
- 102000057361 Pseudogenes Human genes 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 108020001027 Ribosomal DNA Proteins 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 101000803959 Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8) DNA ligase Proteins 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- YVBSAPDHRXHFHV-UHFFFAOYSA-N [chloro(methoxy)methyl]benzene Chemical compound COC(Cl)C1=CC=CC=C1 YVBSAPDHRXHFHV-UHFFFAOYSA-N 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 108010002833 beta-lactamase TEM-1 Proteins 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000005082 bioluminescent agent Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 150000001615 biotins Chemical class 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000005158 carboxyaminoalkyl group Chemical group 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000002230 centromere Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000012767 chemiluminescent enzyme immunoassay Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 239000012468 concentrated sample Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- 230000002559 cytogenic effect Effects 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000009144 enzymatic modification Effects 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- VGEWEGHHYWGXGG-UHFFFAOYSA-N ethyl n-hydroxycarbamate Chemical compound CCOC(=O)NO VGEWEGHHYWGXGG-UHFFFAOYSA-N 0.000 description 1
- GATNOFPXSDHULC-UHFFFAOYSA-N ethylphosphonic acid Chemical compound CCP(O)(O)=O GATNOFPXSDHULC-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 101150073818 gap gene Proteins 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000007614 genetic variation Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000005305 interferometry Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 238000002789 length control Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229940002712 malachite green oxalate Drugs 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000013528 metallic particle Substances 0.000 description 1
- VHGXRGXCDVQIKS-KRWDZBQOSA-N methyl (2s)-3-(4-methylphenyl)sulfonyloxy-2-(phenylmethoxycarbonylamino)propanoate Chemical compound C([C@@H](C(=O)OC)NC(=O)OCC=1C=CC=CC=1)OS(=O)(=O)C1=CC=C(C)C=C1 VHGXRGXCDVQIKS-KRWDZBQOSA-N 0.000 description 1
- DWCZIOOZPIDHAB-UHFFFAOYSA-L methyl green Chemical compound [Cl-].[Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC(=CC=1)[N+](C)(C)C)=C1C=CC(=[N+](C)C)C=C1 DWCZIOOZPIDHAB-UHFFFAOYSA-L 0.000 description 1
- 230000036456 mitotic arrest Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- SHXOKQKTZJXHHR-UHFFFAOYSA-N n,n-diethyl-5-iminobenzo[a]phenoxazin-9-amine;hydrochloride Chemical compound [Cl-].C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=[NH2+])C2=C1 SHXOKQKTZJXHHR-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 238000002966 oligonucleotide array Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000000059 patterning Methods 0.000 description 1
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000004713 phosphodiesters Chemical class 0.000 description 1
- 150000008298 phosphoramidates Chemical class 0.000 description 1
- SXADIBFZNXBEGI-UHFFFAOYSA-N phosphoramidous acid Chemical group NP(O)O SXADIBFZNXBEGI-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- LJZPPWWHKPGCHS-UHFFFAOYSA-N propargyl chloride Chemical compound ClCC#C LJZPPWWHKPGCHS-UHFFFAOYSA-N 0.000 description 1
- MWWATHDPGQKSAR-UHFFFAOYSA-N propyne Chemical compound CC#C MWWATHDPGQKSAR-UHFFFAOYSA-N 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- 125000006853 reporter group Chemical group 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/682—Signal amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6862—Ligase chain reaction [LCR]
Definitions
- DNA and RNA detection is generally accomplished by long DNA probes or by short oligonucleotide probes that complex to the target sequence by complementary hybridization.
- Long probes consist of DNA copies that range from many hundreds to many thousands of bases in length and are derived from various sources including mRNA, isolated and cloned fragments, or PCR amplification of genomic or cloned DNA.
- Such probes are usually labeled by nick translation, random priming, PCR or synthesis. They are then hybridized to the target and detected by radioactive, chemiluminescent, colorimetric or fluorescent signaling.
- probe lengths in the range of about 500 to about 1500 base pairs since such lengths allow secondary interactions between probe components that multiply the number of probe molecules complexed to each DNA or RNA target site.
- large probes cannot be generated since synthetic DNA cannot be efficiently manufactured in lengths greater than 100 base pairs. Consequently, many years have often been expended in simply finding, isolating and copying an adequate portion of the correct DNA target from natural sources.
- DNA detection can be achieved with short synthetic oligonucleotide probes that usually range in size from 20 to 50 bp in length, and such probes can be manufactured from published sequences.
- oligonucleotides provide a more convenient and rapid route to probe development and use, they have far less signaling capacity since maximal labeling is largely limited to the signal amplification potential of terminal transferase tailing. This procedure allows generation of a small group of 10 to 25 bases attached to the 3' end of the oligonucleotide, resulting in a small number of radioactivity labeled bases or accessible haptenated bases for secondary detection. Consequently, synthetic oligonucleotide probes are mostly used to detect amplified or concentrated target samples. For in situ mapping of genomic DNA , they can only be used to detect repetitive sites where sufficient signaling can be achieved by binding multiple copies of the probe to multiple tandem targets.
- Urdea et al. (U.S. Pat. No. 5,124,246) describe a method for amplifying signaling from oligonucleotide probes by sandwiching them to multimers of "comb-like" or linear configurations that are constructed by chemically or enzymatically joining a multiplicity of short synthetic nucleic acids and labeling compounds. These multimers are known as branched or bDNA. However, these multimer structures, which comprise tree or more end-joined parts, depend on the force of hybridization to thether them to the specific probe and the target sequence. Consequently, limited branch structures may be joined to one site and many probes with labeled multimers are required to achieve signaling comparable to long probes. For detecting the N. gonorrhea Tem-1 beta lactamase gene, for example, they describe twenty six oligonucleotide probes that target different sites along the gene, each with an attached multimer.
- Nilsen and Prensky (U.S. Pat. No. 5,487,973) describe a probe and signaling dendrimer constructed of synthetic nucleic acids that form a layered ball, in which the outer layer consists of free and protruding single stranded oligonucleotide arms of two types.
- these dendrimers are custom constructed to target a specific nucleotide sequence, and one type of the multiple free arms will share a specific sequence complementary to the target site, and the other type of the multiple free amis will carry signaling compounds or agents.
- This design can provide signaling which exceeds that of a single oligonucleotide probe, but it depends primarily on the limited forces of hybridization provided by one probe arm to tether the sizable dendrimer.
- Nilson et al. describe long oligonucleotide probes which have two target specific sequences at each end that separately hybridize to adjacent targeted regions in an end to end manner and are then ligated together. Between the target specific sequences at each end lies a long chain of carbon spacers. Once ligated, these probes encircle the DNA and cannot be removed by denaturation. However, the length of these probes make them difficult to synthesize, and their signaling potential is similar to tailed oligonucleotides since the bases that can be labeled are limited. Consequently, their mapping effectiveness is largely limited to repetitive copy sites.
- Somers et al. 1994 [Nucleic Acids Research, Vol. 22, pp. 4840-4841(1994)] describe a method for detecting single base mutations by hybridizing two oligonucleotide probes side by side and ligating them together.
- One probe has a biotin component which provides a means for capture to an avidin coated microtiter plate.
- the other probe has a signal hapten digoxigenin which can be conjugated to a colorimetric or chemiluminescent signaling molecule.
- the Somers' methodology is derived from other published methods on oligonucleotide ligation assays (OLAs). See, e.g. U.S. 4,988,617.
- GAP Gene Amplification Probe
- Such probes consist of a target specific oligonucleotide attached to a DNA reporter molecule at one end.
- GAPs are difficult to hybridize effectively and durably when long reporter DNAs of 500 bp length or greater are utilized. Consequently they have produced inconsistent signaling results proportional to reporter tail length, e.g., nylon membrane dot blots. They have also failed to hybridize and signal as effectively as oligonucleotide probes of identical target sequence in situ hybridization formats such as sectioned brain, lung and prostate tissues.
- the GAP-LOCK probe has a generic linker, known as a probe linker, at one or both distal ends.
- the probe linker provides for the attachment of one or more reporters, such as the reporter molecules of the present invention.
- the GAP-LOCK probe was discovered to provide more stable support for long reporters or multiple reporters and it is especially suitable for detecting single base pair changes in a polynucleotide sequence, e.g., mutations and polymorphic variation.
- the unique advantage of the GAP-LOCK design is its ability to achieve both high specificity and greater signal strength due to its capacity for exponential reporting or labeling.
- WRAP-PROBE suitable for detecting the presence of a polynucleotide sequence.
- the WRAP-PROBE has a critical DNA sequence complementary to the target sequences as well as a generic linker, known as probe linkers, at one or both ends.
- the probe linker provides for the attachment of one or more reporters, such as the reporter molecules of the present invention.
- the advantage of the WRAP-PROBE is its suitability for exponential reporting or labeling without the need for ligation. This probe also has a simple modular design that allows cheap and easy probe development.
- the GENE-TAG reporter has a generic reporter sequence as well as one or more generic linker ends, known as reporter linkers.
- the GENE-TAG reporter molecules are designed to provide exponential signaling by virtue of the fact that multiple reporters can be linked to one another end-to-end to form chained or branched structures of such reporter molecules by hybridization of complementary reporter linkers.
- the generic linkers employed allow these reporter constructs to be joined to a variety of gene probes which contain complementary probe linkers such as the WRAP-PROBEs and GAP-LOCK probes described in the present invention.
- GENE-TAG reporters can be prejoined to one another, can be prejoined to the probes, can be joined to the probes after hybridization to the target, and can be self-assembled or layered in situ to form linear or branched arrays that are attached to the probe.
- the unique advantage of the GENE-TAG method is its suitability for attaching such reporters in a modular manner to probes of different type and to probes specific to different targets. This method is also more suitable for adjusting the degree of amplified labeling according to circumstances.
- Applicant has a polynucleotide structure, known as a Multi-LINKER, that can be interposed between the probe element and the reporter elements to allow the binding of multiple reporters or reporter chains to probe, such as the WRAP-PROBE of GAP-LOCK probe of the present invention.
- Multi-LINKERS can be singular or multiple oligonucleotides made with a series of terminal or internal linking sequences.
- the composite Multi-LINKER can self-assemble by overlapping complementary linking sequences of two or more oligonucleotides.
- the Muli-LINKER has a proximal linker end constructed to be joined to a variety of gene probes which contain complementary linkers such as the WRAP- PROBEs or GAP-PROBEs of the present invention and two or more distal linkers to bind multiple reporters.
- the Multi-LINKER unit can be used in combination with reporters such as short oligonucleotides with labeling units, or with the GENE-TAG reporters of the present invention.
- the unique advantage of the Multi-LINKER is its ability to attach multiple reporters and the resulting capacity for exponential reporting.
- Applicant has also devised a COLOR-TAG modification of the GENE-TAG signal amplification method that is capable of binding or capturing to a probe a specific mix of different GENE-TAG reporters that contain different labeling compounds. This is accomplished by joining a Multi-LINKER structure to the probe that will attract and join GENE-TAGs of a single or mixed color or will join a mix of GENE-TAGs of different colors. This modular design can thereby give each probe a distinct signaling profile based on the mix and or proportion of different labeling compounds which result.
- This COLOR-TAG method is designed to allow mixing of generic GENE-TAG reporters with complementary colors, for example, such as red, green and blue colored fluorescent signaling, and thus each probe could achieve a distinct signature color in the same way that red, green and blue light is ratio mixed in television monitors to create a multitude of distinct colors.
- the unique advantage of this method is that it allows the simultaneous application of multiple probes, with each probe carrying or capturing of GENE-TAG reporters that define and differentiate that probe from other probes.
- Capture GAP-LOCK method that is more suitable for detecting small targets or unstable targets like RNA, or where liquid hybridization conditions are needed or more favorable.
- This design provides a first probe element with a capture molecule or a capture potential and no reporter potential and a second probe element providing reporter potential.
- RING-TAIL modifications of both the GAP-LOCK and WRAP-PROBE designs that cause these probes to encircle the target polynucleotide upon application of the method. Some of these components are preferably crosslinked together.
- the combination of a RING-TAIL unit with GAP-LOCK components produces a circular RING-LOCK probe that is closed by ligation.
- the combination of a RING-TAIL unit with a WRAP-PROBE produces a circular WRAP-LOCK probe that is closed by hybridization, and these hybridized components may then be crosslinked together to form a covalently closed circle.
- the unique advantage of these RING-TAIL modified methods is that they make the probe highly resistant to removal.
- the RING-LOCK probe is also particularly suitable for detecting rare mutations by applying double probes with two different colors or labels that separately detect the altered sequence in both the sense and antisense strands of genomic DNA.
- This enhanced DOUBLE-LOCK method offers the potential to detect pre cancerous cells hidden in a sea of normal cells or to detect mutant virus about to emerge and overwhelm a weakened host.
- the invention disclosed herein includes methods, reagents and compositions for detecting nucleic acid sequences, for mapping such sequences in genomic samples or tissues, and for discriminating polymorphic genetic variations or single base mutations.
- the invention includes a number of related designs for gene probe components, multilinking components and signaling components, all of which are modular in nature and can be used together or in part.
- Virtually all of the probe, reporter and multilinking components are constructed of synthetic oligonucleotides or amplified DNAs, and they are generally joined together in composite structures by hybridization of complementary sub-segments, called linkers. Linkers are designed to avoid sequences that occur in the targeted samples and they are designed to facilitate binding by crosslinking or other chemical methods as needed.
- the reporters are also designed to be conjoined into arrays that can provide amplified signaling.
- the multilinking components of the present invention may be interposed between the probe and the reporter units and provide for the binding of multiple reporters.
- Various modifications of the present invention can facilitate target specificity, the structural tethering of the probe, and its ability to support modular signaling components of greater length or mass.
- These probe and signaling methods also include means to achieve mixed-color labeling that is specific to each target.
- WRAP-PROBE Helically wrapped probe that can attach multiple reporters, chained reporters or branched reporters
- GENE-TAG Linear reporter molecules that can attach end to end in chained or branched configurations
- RING-TAIL Polynucleotide complex that joins probe components into a potential ring structure and provides end linkers for reporters RING-LOCK Complex of GAP-LOCK probe unit and RING-TAIL unit to produce a high specificity ligated circular probe with linkers for reporter attachment
- LINKER a single stranded nucleotide segment, that is not complementary to the target sequences, and which provides a means to bind probe and reporter components together by virtue of complementary sequences in the linker
- Multi-LINKER a single polynucleotide or a composite or two or more polynucleotides and other matter which has one or more proximal linkers that bind to a probe element and two or more distal linkers that bind to reporter elements such as GENE-TAGs.
- COLOR-LINKER a polynucleotide having a sequence to the central sequence of the GENE-TAG of a particular color
- TERMINATOR a simple oligonucleotide that is complementary to a distal linker and that blocks further chaining of GENE- TAGs, TINKER-TAGS or other linear arrays
- FIG.l GAP-LOCK Probe method.
- 1A depicts dual probes each synthesized with a distal linker.
- IB depicts hybridization of dual probes to target sequence in tandem.
- IC depicts an alternative construction of the GAP-LOCK probe where one probe is made with a reversing linker in order to provide dual probes having a linker end of the same orientation.
- ID depicts a three dimensional view after dual probe ligation showing a helically wrapped configuration.
- IE depicts alternate binding of single reporters or a chain of reporters to each GAP-LOCK probe distal linker.
- FIG.2 The GAP-LOCK method.
- 2 A depicts an alternative GAP-LOCK probe construction wherein one or more probes are prejoined to PCR generated reporters.
- 2B depicts hybridization of dual probes to target sequence in tandem
- 2C depicts a bar graph of the results of Example 1, showing high retention of ligated GAP-LOCK probes with long reporters even after denaturation.
- 2D depicts an alternative GAP-LOCK probe construction with dual probes on either end of same template.
- 2E depicts an alternative GAP-LOCK construction wherein one or both probes are prejoined to reporter DNA sequence having a terminal linker for joining additional generic reporter DNAs.
- FIG. 1 depicts an alternative GAP-LOCK probe construction wherein one or more probes are prejoined to PCR generated reporters.
- 2B depicts hybridization of dual probes to target sequence in tandem
- 2C depicts a bar graph of the results of Example 1, showing high retention of ligated GAP-LOCK probes with long reporters
- 2F depicts an alternative GAP-LOCK method, the Capture GAP-LOCK method, with a capture moiety joined to the distal end of one probe and not a reporter element, and a reporter element bound to the distal end of the other probe, suitable for use in liquid hybridization conditions and applicable to any formats.
- 3 A Depicts construction of a typical synthetic WRAP-LOCK probe.
- 3B depicts an alternative synthetic construction to provide 3' ends and alternative means to use longer probe elements made enzymatically.
- 3D depicts hybridization of the WRAP-PROBE to target, which provides a helically wrapped configuration.
- FIG.4 GENE-TAG method.
- 4A depicts manufacture of GENE-TAG reporters by PCR.
- 4B depicts chaining of GENE-TAGs and length control by ratio mix with Terminal- TAGs or Terminator oligonucletides.
- 4C depicts hybridization of GENE-TAGs to WRAP- PROBE to provide amplified signaling.
- FIG. 5 GENE-TAG method. 5 A depicts the results of the two experiments of Example 4 with WRAP-PROBEs and different sized chains of GENE-TAGs. 5B depicts ' construction of synthetic GENE-TAG chains using overlapping oligonucleotides and length controlled by ratio mixing with Terminator oligomers.
- FIG. 6 TINKER-TAG method.
- 6A depicts construction of synthetic GENE-TAGs made with side arms for secondary attachment of label agents.
- 6B depicts assembly of TINKER-TAG chains that are length controlled by ratio mixing with Terminator oligomers.
- FIG. 7 Duo/Layered GENE-TAG method.
- 7A depicts construction of two types of GENE-TAGs with alternating non-complementary linker pairs so that one type will layer on the other but will not form chains in solution.
- 7B depicts successive application of the Type I and Type II GENE-TAGs to grow signaling as needed.
- FIG. 8 depicts comparison of pre-joined and layered GENE-TAGs applied to WRAP- PROBEs.
- the WRAP-PROBE for 1-LO-l gene provided in different concentrations, binds to target samples on membrane mini-arrays known as Reverse Dot Blots which simulate the conditions of cDNA chip arrays.
- 8 A depicts concentration dependent binding and labeling of probe to 15-LO-l targets with chained GENE-TAGs made with ratio of 3 GENE-TAGs per terminator.
- 8B depicts concentration dependent binding and labeling of probe to 15-LO-l targets with layered GENE-TAGs wherein adding successive GENE-TAG layers of Type I, II and I provides increasing signaling that contrasts with that of chained GENE-TAGs.
- FIG. 9 Double-Duo GENE-TAG method.
- 9A depicts construction of two types of GENE-TAGS with alternating, non-complementary, linker pairs with two distal linkers.
- 9B depicts successive application of Type I and Type II GENE-TAGS that amplifies two fold with each layer.
- FIG. 10 COLOR-TAG method, a variation of the GENE-TAG method allowing multi-colored reporters that bind to specific probes in different proportions giving each probe a distinct signature color.
- 10A depicts manufacture of different GENE-TAGs to give different colors.
- 10B depicts construction of three different WRAP-PROBEs for this method and representing three of the four probes needed for Example 12.
- FIG.1 1 COLOR-TAG method.
- 11A depicts synthesis of COLOR-LINKERS.
- 1 1B depicts assembly and joining of first probe (A) with COLOR-LINKER only containing "red” acceptor sequences.
- 1 IC depicts similar assembly of second probe (B) with COLOR- LINKER containing only "green” acceptor sequences.
- 1 ID depicts assembly of a third probe (C) with COLOR-LINKER containing mixed "red” and "green” acceptor components.
- FIG.12 COLOR-TAG method. 12A depicts hybridizing of the three probes of FIG. 11, containing variant COLOR- LINKERS, to their respective targets. 12B depicts applying a mix of COLOR-TAGs to label each of the three probes differently and simultaneously in order to map the location of each gene or sequence targeted.
- FIG. 13 Cells with fluorescent in situ hybridization (FISH) labeling of WRAP- PROBEs for gene sites with "Green” only COLOR-TAGs, “Red” only COLOR-TAGs, and two mixed “Red” and “Green” COLOR-TAGs using method of Example 12.
- FISH fluorescent in situ hybridization
- FIG.14 Multi-LINKER method.
- 14A depicts the elemental Multi-LINKER structure having a minimum of three linking sites, one proximal and two distal, on one molecule.
- 14B depicts a composite Multi- LINKER structure to provide a WRAP-PROBE with 8 GENE- TAG binding linker sites on each end of the probe.
- FIG.15 Multi-LINKER method.
- 15A depicts a pair of composite Multi-LINKERs providing multiple binding sites for short oligonucleotides with prejoined labels, such as Cy3 and Cy5, that cannot efficiently label GENE-TAGs or standard probes by enzymatic means.
- 15B depicts assembled Multi-LINKER and labeled oligomers being added.
- FIG.16 GAP-LOCK Capture Probe method.
- 16A depicts assembly of one probe with distal capture moiety and a second probe with a distal TINKER-TAG reporter.
- 16B depicts hybridization and ligation of the dual probe components with target strand.
- 16C depicts capture of ligated GAP-LOCK with TINKER-TAG attached and the application and detection of aequorin conjugated Label subunits to discriminate sequence targeted.
- FIG.17 RING-LOCK probe method to encircle the target site and detect single base changes.
- 17A depicts synthesis and assembly of dual probe and RING-TAIL components.
- 17B depicts hybridization and ligation of probe to form closed circle; and application and detection of reporters.
- FIG. 18 WRAP-LOCK probe method, to avoid ligation step of RING-LOCK method.
- 18A depicts synthesis and assembly of WRAP-PROBE with RING-TAIL components.
- 18B depicts hybridization of probe and application of overlapping Lock component to close loop as well as application and detection of reporters.
- FIG. 19 DOUBLE-LOCK probe method, to confirm mutation or sequence detection.
- 19A depicts preparation of two probes with different linkers that target the sense and antisense strands of the same target site.
- 19B depicts application of Type 1 reporters to the sense probe and Type 2 reporters to the antisense probe such that low frequency mutations or alterations can be detected.
- FIG. 20 GOLD-TAG method depicts gold particles conjugated to short oligonucleotides and joined to TINKER-TAG units, with the labeled TINKER-TAGs then applied to a WRAP-PROBE and target complex. Silver is then precipitated onto gold particles to form large clusters of silver grains, which may then be detected.
- FIG. 21 A depicts use of the WRAP-PROBES with other commercially signaling units, such as dendrimers and bDNA or multimers.
- 21B depicts the result of Example 9 showing sensitive detection of GAP-LOCK First Probes with aequorin labeling.
- the present invention relates to a number of probe components, multilinking components and signaling components.
- the present invention relates to a reporter, known as a GENE-TAG, suitable for joining to a probe either alone or in combination with another GENE-TAG reporter, comprising a labeled, double-stranded polynucleotide sequence having one or more first linkers, said first linker comprising a single-stranded nucleotide sequence hybridizable to a complementary single-stranded nucleotide sequence, whereas said first linkers is not hybridizable to a target sequence of said probe.
- a reporter known as a GENE-TAG
- suitable for joining to a probe either alone or in combination with another GENE-TAG reporter comprising a labeled, double-stranded polynucleotide sequence having one or more first linkers, said first linker comprising a single-stranded nucleotide sequence hybridizable to a complementary single-stranded nucleo
- the GENE-TAG of the present invention also has one or more second linkers opposed to said first linker, said second linker comprising a single- stranded nucleotide sequence hybridizable to a complementary nucleotide sequence, wherein said second linker is not hybridizable to a target sequence of said probe.
- the first and second linkers of the GENE-TAG may or may not be complementary. Where the first and secon linkers are complementary, a reporter array suitable for joining to a probe is formed, comprising two or more of the GENE-TAGs, linked together end-to-end by hybridization of the second linker of a first GENE-TAG to the first linker of a second GENE- TAG, and optionally, additional GENE-TAGs linked to the remainder of the array by hybridization of the first linker of each subsequent GENE-TAG to the second linker of the preceding GENE- TAG in the array, to form a chained or branched configuration having one or more terminal ends, said terminal end comprising a second linker of a terminal GENE- TAG.
- the reporter array may also have a terminator at one or more of the terminal ends, said terminator comprises a single-stranded nucleotide sequence complementary to the second linker of one or more terminal GENE-TAGs.
- a reporter array is formed using two types of GENE-TAGS.
- the array is formed by end-to end hybridization of the second linker of a first GENE-TAG to the first linker of a second GENE- TAG, and hybridization of the second linker of a second GENE-TAG to the first linker of said first GENE-TAG, and optionally, additional non-complementary GENE-TAGs linked to the remainder of the array by hybridization of the first linker of each subsequent GENE-TAG to the complementary second linker of the preceding GENE-TAG in the array, to form a chained or branched configuration.
- the first and second reporter linkers are not complementary, it is unecessary to use a terminator.
- the present invention also relates to a probe component, suitable for hybridizing to a target nucleotide sequence, said probe comprising a first terminal linker, a second terminal linker, and a central sequence complementary to said target nucleotide sequence, wherein said first and second terminal linkers comprise single-stranded nucleotide sequences hybridizable to a complementary nucleotide sequence, but not hybridizable to the target nucleotide sequence of said probe.
- the present invention also relates to composite probes which can be joined tightly to a particular target strand or sequence, said composite probes comprising at least one probe, said probe comprising a polynucleotide sequence complementary to said target nucleotide sequence, said composite probe further comprising a polynucleotide ring unit, wherein said polynucleotide ring unit is joined to said probe to form an incipient closed loop.
- the composite probe of may a dual probe component, wherein a first probe comprises a sequence complementary to a first region of said target nucleotide sequence, and wherein a second probe comprises a sequence complementary to a second region of said target sequence, wherein said ring unit is joined to said first probe and to said second probe, thereby forming an incipient closed loop.
- the present invention also relates to the design and imployment of interconnecting polynucleotide compositions, called MultiLinkers, designed to join, align or multiplex different probe and reporter units together.
- the Multi-LINKER comprises a first polynucleotide comprising a first terminal linker, a second terminal linker, and at least one internal linker, wherein said first terminal linker, and at least two of said internal and second terminal linkers are hybridizable to complementary nucleotide sequences, and wherein said first and second terminal linkers and said internal linker are not hybridizable to a target sequence of said probe.
- the Multi-LINKER may also have multiple additional polynucleotides, said additional polynucleotide comprising a first terminal linker, at least one internal linker, and a second terminal linker, wherein the first polynucleotide is joined to the additional polynucleotides by hybridization of the additional polynucleotide to the internal or second terminal linker of the first polynucleotide, and wherein said first and second terminal linkers and said internal linker are not hybridizable to a target sequence of said probe.
- the present invention also relates to a method of detecting a target sequence, known as a GAP-LOCK method, said method comprising: a) rendering the target nucleotide sequence substantially single-stranded to give a single-stranded target nucleotide sequence; b) hybridizing the target sequence with a first probe and with a second probe, wherein said first and second probes hybridize at tandem locations on the target nucleotide sequence, wherein each of said first and second probes comprises a proximal ligation end and wherein one or both of said first or second probes further comprises a distal linker, said distal linker comprising a single-stranded nucleotide sequence that does not hybridize to the target nucleotide sequence; wherein said distal linker is joined to one or more reporters, either prior to or subsequent to the hybridization of the first and second probes to the target sequence; c) ligating the hybridized first and second probes at their respective proximal ligation ends to form
- both the first and second probes have a distal linker.
- This GAP -PROBE method has been shown to provide stable support for long or multiple reporters.
- the GAP-LOCK method of the present invention can also be used under liquid or near-liquid hybridization conditions, wherein said first probe comprises a distal end that is joined to a capture moiety, and said second probe has a second distal linker, wherein the hybridization complex is denatured to remove the target sequence, and capturing the GAP- LOCK probe to detect the reporter.
- the capture moiety can be joined to the distal linker of a first probe.
- This embodiment of the GAP-LOCK method is known as the Capture GAP-LOCK method.
- the present invention also contemplate other methods for using of GENE-TAG probes, including composite probes, which hybridize to the probe to form a ring structure or an incipient ring strucutre.
- the present invention relates to a RING-LOCK method for providing a circular enclosure of a target strand by a composite probe , said method comprising: a) providing a target strand comprising a target sequence; b) providing a GAP-LOCK probe, wherein said GAP-LOCK probe has a first and second distal linker; c) providing a RING-TAIL Unit comprising at least three single-stranded polynucleotides, wherein at least one single-stranded polynucleotide is joined or suitable for joining to the first distal linker, and wherein at least one single- stranded polynucleotide is joined or suitable for joining to said second distal linker; and wherein at least one single-stranded polynucleotide
- the present invention also relates to a method of simultaneously detecting a target sequence on both a sense and an antisense strand of DNA, known as a DOUBLE RING- LOCK method, comprising: a) providing a double-stranded DNA comprising a sense target strand and an antisense target strand, wherein said sense target strand comprises a sense target sequence, and wherein said antisense target strand comprises an antisense target sequence; b) providing a sense GAP-LOCK probe, said GAP-LOCK probe having a first and second distal linker; c) providing an antisense GAP-LOCK probe, said GAP-LOCK probe having a first and second distal linker; d) providing a first RING-TAIL Unit comprising at least three first single- stranded nucleotides, wherein at least one said first single-stranded nucleotide is joined or suitable for joining to said first distal linker of said sense first probe, and wherein at least one said first single-
- the GAP-LOCK method of the present invention involves formation of a ligated dual probe having one or more reporters attached directly thereto.
- This embodiment of the GAP-LOCK method for detecting a target nucleotide sequence comprises: a) rendering the nucleotide sequence substantially single-stranded to give a single-stranded nucleotide sequence; b) hybridizing the target sequence with a first probe and a second, wherein said first and second probes hybridize at tandem locations on the target, wherein each of said first and second probes comprises a proximal ligation end, and a distal end pre-joined to one or more reporters; c) ligating the hybridized first and second probes at their respective proximal ligation ends to form a GAP-LOCK probe; d) denaturing or washing to remove any unligated first and second probe; e) determining whether the target nucleotide sequence is present by detecting the presence or absence of said reporter or reporters.
- the distal end is pre-joined directly to a first reporter comprising a labeled, double-stranded polynucleotide generated by PCR.
- the first reporter may also have one or more distal reporter linkers, said distal reporter linker comprising a single-stranded nucleotide sequence hybridizable to a complementary nucleotide sequence, said distal reporter linker not hybridizable to the target nucleotide sequence.
- the distal reporter linker may be suitable for hybridizing to a labeled, double- stranded DNA sequence, known as a GENE-TAG, comprising one or more first reporter linkers, wherein said first reporter linker comprises a single-stranded nucleic acid sequence hybridized to the distal reporter linker of said first reporter.
- reporter array comprising a first labeled, double-stranded polynucleotide sequence, known as a GENE-TAG, linked together end-to-end by hybridization to one or more GENE- TAGS, wherein said first GENE-TAG comprises one or more first reporter linkers, said reporter linker comprising a single-stranded nucleotide sequence hybridizable to the distal reporter linker of said first reporter, and one or more second reporter linkers hybridized to one or more first reporter linkers of a second GENE-TAG, and wherein said second GENE-TAG further comprises one or more second reporter linkers, and optionally, additional GENE- TAGs linked to the remainder of the array by hybridization of the first reporter linker of each subsequent GENE-TAG to the second reporter linker of the preceding GENE-TAG in the array, to form a chained or branch configuration having one or more terminal ends, said terminal end comprising the second reporter linker
- the present invention also relates to a method of detecting a target nucleotide sequence, known as the WRAP-LOCK method, comprising: a) rendering the target nucleotide sequence substantially single-stranded to give a single-stranded target nucleotide sequence; b) hybridizing the single-stranded target nucleotide sequence with a nucleic acid probe, thereby forming a hybridized WRAP-PROBE complex of a single- stranded target nucleotide sequence and a nucleic acid probe, said WRAP- PROBE comprising a central sequence complementary to the single-stranded target nucleotide sequences, and further comprising a probe linker at one or both terminal ends, said probe linker comprising a single-stranded nucleotide sequence that does not hybridize to the target sequence; wherein said probe linker sequence is joined to one or more reporters, either prior to or subsequent to the hybridization of the probe to the target sequence; c) washing to remove any un
- the WRAP-LOCK method provides for circular enclosure of the target polynucleotide strand with a WRAP-PROBE, which method comprises: a) providing the WRAP-PROBE having a first and second terminal probe linker; b) providing a RING-LOCK Unit comprising at least two single-stranded polynucleotides, wherein at least one single-stranded polynucleotide is joined or suitable for joining to said first terminal probe linker, and wherein at least one single-stranded polynucleotide is joined or suitable for joining to one or more reporters; c) treating the probe and RING-TAIL unit, at this step or another step, to effect cross linking or to increase binding; c) hybridizing the WRAP-PROBE to the target strand, thereby forming a hybridized complex; d) joining at least one single-stranded polynucleotide to said first terminal probe linker, if not previously joined, e) providing a
- the present invention relates to a method of simultaneously detecting a target sequence on both a sense and anti-sense strand of DNA, known as the DOUBLE- WRAP LOCK method, said method comprising: a) providing a double-stranded DNA comprising an antisense strand and a sense strand, wherein both said antisense strand and said sense strand comprise a target sequence; b) providing a sense WRAP-PROBE having a first and second terminal probe linker, said sense WRAP-PROBE probe having a central sequence complementary to the sense strand target sequence; c) providing an antisense WRAP-PROBE having a first and second terminal probe linker, said antisense WRAP-LOCK probe having a central sequence complementary to the antisense strand target sequence; d) providing a first RING-TAIL Unit comprising at least two first single-stranded polynucleotides, wherein at least one first single-stranded polynucleotide is
- the method of the present invention also relates to a method for exponential signal amplification, known as the GENE-TAG method, comprising: a) providing a single-stranded target nucleic acid sequence; b) providing a probe comprising a sequence hybridizable to said target nucleic acid sequence, and a terminal linker sequence on one or both ends of the probe, wherein said linker sequence is a single-stranded polynucleotide hybridizable to a complementary sequence; c) providing one or more GENE-TAGs, said GENE-TAG comprising a labeled, double-stranded polynucleotide reporter having one or more first reporter linkers and one or more second reporter linkers opposed to said first reporter linker, said reporter linkers comprising single-stranded polynucleotide sequences not hybridizable to the target sequence, wherein at least one said
- GENE-TAG has a first reporter linker complementary to said probe terminal linker, and wherein one or more said reporter linkers link together end-to-end by hybridization of the first reporter linker of each subsequent GENE-TAG to the second reporter linker of each preceeding GENE-TAG in the array, to form a chained or branched configuration comprising one or more terminal end, wherein said terminal end comprises the second reporter linker of a terminal GENE-TAG; wherein said GENE-TAG is joined to said probe and this or a subsequent step; d) hybridizing said probe to said target nucleotide sequence; e) joining said GENE-TAG or GENE-TAGs to said probe, if not so previously joined; f) determining the presence of the target sequence by detecting the presence of the GENE-TAG or GENE-TAGs.
- the first and second reporter linkers of the GENE-TAGs are complementary, such that only GENE-TAGs of one type are required to form chained or branched reporter arrays.
- the length of said chained or branched reporter arrays, and thus probe amplification, may be controlled controlled by the ratio of GENE- TAGs to said terminators.
- a Terminator TAG represents one such terminator, said Terminator TAG comprising a GENE-TAG having no second reporter linker, wherein said first reporter linker of said Terminator TAG hybridizes to the second reporter linker of a terminal GENE-TAG of the chain or branch.
- the first and second reporter linkers of the GENE-TAG are not complementary.
- the method requires at least two tyoes of GENE-TAGs to form chained or branched arrays, wherein GENE-TAGs of a first type comprise a first reporter linker complementary to the probe terminal linker, and a second reporter linker complementary to the first reporter linker of GENE-TAG of the second type, and wherein said GENE-TAG of the second type has a first reporter linker complementary to the second reporter linker of a GENE-TAG of the first type, such that only a GENE-TAG of the first type will bind to a GENE-TAG of the second type, and only a GENE-TAG of the second type will bind to a GENE-TAG of the first type; wherein said chained or branched arrays are formed by providing GENE-TAGs sequentially, alternating between the first and second type, and
- GENE-TAGS are constructed by PCR amplification of arbitrary template DNA using one or more modified oligonucleoties as primers, wherein each modified oligonucleotide has one or more internal spacers, whereby the first and second terminal single-stranded linkers are preserved.
- GENE-TAGs are constructed by hybridization of two polynucleotides, said first polynucleotide having a second terminal end complementary to the first terminal end of a second polynucleotide.
- TINKER TAGs represent the GENE-TAG structure formed when the first polynucleotide has an internal sequence complementary to the internal sequence of a second polynucleotide, forming a GENE-TAG having side arms, said side arms comprising the second terminal end of the first polynucleotide, and the first terminal end of the second polynucleotide.
- These TINKER-TAGs may be labled indirectly, by binding short oligonucleotides bearing label units.
- the present invention also relates method of constructing probes detectable on the basis of a unique signal, which method permits simultaneous detection of more than one probe.
- This method known as the COLOR-TAG method, comprises: a) providing a probe hybridizable to a single-stranded nucleotide sequence, wherein said probe comprises a terminal linker at one or both ends, said terminal linker comprising a single-stranded polynucleotide capable of binding to a complementary sequence; b) preparing on or more COLOR-TAGs, said COLOR-TAG comprising a double-stranded polynucleotide reporter having a first reporter linker and a second reporter linker opposed to said first reporter linker, wherein said COLOR-TAG is labeled with one or more labels or colors, or both, and wherein said first and second reporter linkers are specific to the labels or colors employed; wherein at least one COLOR-TAG terminal linker is hybridizable to the terminal linker of said probe
- the COLOR- TAG method may also include an intermediate multilinking structure, linking the probe to two or more reporters.
- This multilinking structures serves to increase the number of COLOR-TAGs that can be joined to a given probe, and therefore the possible COLOR-TAG combinations that can be used to unqiuely identify a probe.
- the multilinker structure contains one or more color acceptor sequences, called COLOR-LINKERS, which sequences are specific to the linkers of a particular COLOR-TAG. In this way, multilinkers can be designed to attract particular COLOR-TAGS, to give a characteristic label to a particular probe.
- the COLOR-TAG may have two or more different labels or colors associated therewith.
- the present invention relates to a new class of reagents and methods for detecting nucleic acid sequences comprising complexes of synthetic probes and generic reporter molecules in which the nucleic acid probe component recognizes and binds to the target sequence by hybridization, but it is helically wrapped around the target, and it is bound to one or more polynucleotide reporter molecules from one or both ends, wherein the probe and reporter complex are thereby tethered to the target strand by forces which exceed that of simple hybridization.
- This configuration, and alternate configurations which more completely encircle the target, and/or which provide an multiple linking component, provide a basis for the attachment of extended and multiple polynucleotide reporters, in chained or branched configuration, which can be constructed beforehand, which are composed of synthetic oligonucleotides and or modified amplicons of deoxyribonucleic acid which have been made or rendered partially single stranded on their termini so that they can link up end to end.
- Various components of these probe and reporter systems as well as probe and target complexes are more firmly joined together by covalent crosslinking or by employing artificial nucleotide bases with greater binding capacity.
- hybridized linkages that will occur between probe and reporter components, or between an interposed multilinking structure and these components are designed such that these bonds will generally pull end to end rather than laterally under the conditions employed.
- This structural principal sums the hydrogen bonds between linkers together in the same manner that the hooks and eyes of joined Velcro strips have amplified binding when pulled end to end versus laterally.
- the principal probe methods and compositions are based on the GAP-LOCK and WRAP-PROBE designs, including the Capture-GAP-LOCK method, and the principal signal amplification methods and compositions are based on the GENE-TAG and COLOR-TAG designs.
- the GAP-LOCK design entails two probes, one with a 5' head end and the other with a 3' head end, that hybridize to adjacent tandem sites on the target and that carry extended or multiple reporter structures or have the capacity to attach such reporters. If the match is exact between the probe and target, in the bases immediately near the gap between the probes, then they can be ligated together. Successful ligation confers a centralized, structurally-wrapped configuration that effectively tethers the probe and the extended reporters to the target site and stabilizes them against washing and/or denaturation. Signal retention thus indicates detection of the mutation or base change targeted, while failure to ligate, prevents or leads to loss of signal and indicates the absence of the target sequence. Consequently, when this invention is applied, it provides the simultaneous advantage of improving both the detection of small base changes and the amplification of signaling.
- GAP-LOCK probes are manufactured in several modifications, the primary embodiment being two probes with distal linkers, with reporters linked to the probes afterwards or beforehand. In one embodiment, one or both of the probes are prejoined to
- the reporter may have one or more terminal linkers for binding one or more reporters.
- the probes are synthesized having a distal terminal linker for the attachment of a reporter having a complementary sequence, prior to or subsequent to probe hybridization. See Figure 1 A.
- GAP-LOCK probes have been manufactured wherein the dual probes have been joined to the same double-stranded reporter, with the 5' probe on one end and the 3' probe on the other end.
- FIG 2D With formats that approximate or favor liquid hybridization conditions, such as microwell plates, and with small or unstable targets, such as DNA or RNA samples used with various DNA chip formats (oligonucleotide arrays, optical chips, cDNA arrays), these probe subunits can be constructed so that one probe linker can be affixed with capture moieties, to complex the probe to a substrate, while the other probe linker can be affixed with reporters.
- the target strand can be removed after hybridization and ligation, leaving a ligated GAP-LOCK complex intact to capture the reporter and to provide definitive signaling.
- the WRAP-PROBE design extracts the central structural feature of the GAP-LOCK design, namely, the centralized, helically-wrapped probe configuration of the method, which effectively wraps the ligated probe complex around the target site and joins one or more reporters from one or both sites.
- this embodiment involves a single probe, avoiding the need for ligation. Therefore, the probe complex consists of a target specific segment of nucleic acid sequences, midway within the probe, and attachment sites or linkers at one or both ends of the probe. After the probe component is hybridized to the target site, one or more reporters are linked directly to the ends of the probe or to intermediate multilinking structures.
- This helical and linear orientation of the probe, of the linkers, or multilinker structures, and of the reporters are designed to both stabilize the probe and to support multiple or highly extended reporters. At the same time, the need for ligation is eliminated. This design can therefore improve specificity, it allows exponential signaling, and it simplifies the manufacture of new probes for different targets.
- the WRAP-PROBE units were synthesized as two overlapping oligonucleotide subunits which are joined together. See Figure 3B.
- the oligomers (and all subsequent oligomers for probe and reporter components) were made with a DNA synthesizer using phosphoramidite chemistry.
- the primary probe subunit contains first linker sequences on the
- the secondary probe subunit is generic and lacks target specific sequences, while its 3' end is complementary to the second linker sequences of the primary probe subunit, and its 5' end contains first linker sequences complementary to the reporter unit.
- the 3' linker sequences are designed with 5' TA sites to facilitate psoralen plus UV crosslinking.
- Such crosslinking employs a bi- or tri-functional reactive psoralen compound which intercalates between paired bases, and, upon exposure to long wave UV light (blacklite), forms a covalent bridge between thymidine bases that are adjacent to but opposite one another on facing complementary strands.
- the probe unit can be made with 3' linker ends or as a single oligomer which is synthesized with linker sequences on both ends and target specific sequences in the middle. In the latter case, each end will attach reporters differently.
- Such WRAP-PROBE units can also be manufactured by cloning or PCR amplification of a target specific segment to which linkers on one or both ends are attached by a second annealing/hybridization step similar to the attachment of the linker subunit in the principal WRAP-PROBE method described above. See Figure 3C.
- the present embodiment of a WRAP-PROBE entailed a structure which is complementary to the target sequences in the central region of the probe unit and each terminal region contain a probe linker sequence for reporter attachment, or attachment of a multilinking unit. See Figure 3B.
- This probe is distinguished by the initial formation of a probe that wraps around the targeted sequences at midpoint ( Figure 3D) and by the secondary binding of reporters to the terminal linkers such that the reporters are thereby structurally tethered to the targeted location.
- the GENE-TAG design extracts the reporter component of the GAP-LOCK design and makes it a generic product capable of attaching to any WRAP-PROBE, to any GAP- LOCK probe modified to accept such reporters, or to any other probe design that provides appropriate generic linkers for attachment.
- the typical embodiment of the GENE-TAG reporters are extended segments of arbitrary reporter DNA with terminal linker ends that can attach to the probe and/or to other such reporters. See Figure 4A. Depending on the sequences or the nature of the linkers employed, such reporters can form extended chains or branching structures of such reporters. See Figure 4B.
- reporter arrays can then bind to a hybridized probe such as a WRAP -PROBE and produce signaling which is largely proportional to the length and density of the reporter arrays. See Figure 4C and 5 A.
- the invention also includes several modifications of this design to suit different requirements and conditions as well as procedures to limit or control the growth of reporter arrays.
- These GENE-TAG components can also be manufactured by different processes.
- the primary embodiment is based on PCR amplification using spacer modified oligonucleotides as primers to produce single stranded linkers on either end of a generic reporter template. See Figure 4A. However, means are also devised to create similar structured reporters assembled from overlapping oligonucleotides. See Figure 5B.
- One version of this design also known as the TINKER-TAG method, provides secondary linker side arms to allow interchangeable labeling elements that are applied separately. See Figure 6A and 6B.
- the key aspect of all these methods is the facility for modular, amplified signaling.
- the PCR generated reporters of the present invention generally consists of long segments of labeled double-stranded DNA (generally 100 - 800 bp) with short single-stranded tails (generally 20 - 30 bp) on one or both ends to serve as linkers.
- the base pair sequences within the long double-stranded portion are arbitrary and these bases only serve to carry signaling elements.
- the single-stranded tails have specific linker sequences that are complementary to the probe unit, to other reporter units, or to a multilinking structure.
- GENE-TAG reporters were manufactured with staggered single-stranded linkers at each end wherein the first or proximal linker is complementary to the linker sequence of the probe, and wherein the second or distal linker is complementary to the first linker of the same GENE-TAG or another GENE-TAG. While this design would theoretically allow the ends of a reporter or reporter chain to self join as a closed circle, such events are largely prevented by the limited flexibility of double-stranded DNA. Thereafter, these complementary double- tailed reporters generally join to one another on an end-to-end basis, forming a linear chain that amplifies signaling.
- Terminal TAGs A smaller proportion of said reporters were constructed with only one single-stranded end, hereinafter termed Terminal TAGs, and this end contains sequences that are complementary to both the probe unit and to the second linker of a GENE-TAG.
- Terminal TAGs These one-ended Terminal TAG units serve to cap a growing reporter chain or to simply provide a singular reporter unit.
- Chains of GENE-TAG units were made to statistically predictable length by mixing a proportion of Terminal TAGs in with an equal or larger concentration of double-ended GENE-TAGs.
- Figure 4B While some variability in chain length will occur with this method, the relative length of the reporter chain can be determined by the ratio of GENE-TAGs to Terminal TAGs employed.
- reporter chains can be capped and controlled in length by ratio mixing GENE-TAGs with a simple oligonucleotide, called a TERMINATOR, having the same sequences as the linker of a Terminal TAG.
- GENE-TAGs may be designed to form a defined reporter chain using a series of paired linker sequences between TAG units such that the first reporter would join to the probe, the second reporter would sequentially join to the first reporter, the third reporter to the second reporter, and so on. See Figure 7.
- These reporter chains could then self-assemble in place, they could be prejoined, or they could be added sequentially as needed to provide the required signaling. With this method, Terminal TAGs or Terminators would be unnecessary.
- Such defined chaining was accomplished using only two types of GENE-TAGS (Type I and II) that were sequentially added in layers. In this embodiment, the proximal and distal linkers of each type of GENE-TAG are not complementary to one another.
- the TYPE I GENE-TAG has a proximal linker that attaches to the probe, and a distal linker that attached to the proximal end of a Type II GENE-TAG.
- a Type II GENE-TAG has a distal linker that will bind to the proximal end of a Type I GENE-TAG.
- a Type I will only bind to a Type II and a Type II will only bind to a Type 1, so that when kept separate they will not bind to form chains.
- a chain is created by layering, with the probe applied first, Type I GENE-TAGs next, Type II next, and back to Type I, with a simple wash between successive GENE-TAG applications.
- the distal ends of the Type I and Type II GENE-TAGs can be made with two or more distal linkers, such that each layer will exponentially bind more GENE-TAGs. See Figure 9.
- GENE-TAGs and Terminal TAG reporter units were made using modified oligomers as primers to amplify arbitrary template DNAs.
- the template DNAs are typically derived from cloned inserts of Mi 3 or other plasmids such as pGEM3, and the size of the inserts (typically 100 to 800 bp) determines the length of the resulting reporter unit.
- the modified oligomers were synthesized as linear products with three functional regions: a 5' end containing 20-30 nucleotides of a linker sequence, an mid-section of two C9 spacers, and a 3' end containing 15-25 nucleotides of a Ml 3 forward or reverse primer sequence.
- C9 spacer phosphoramidites insert a mixed polarity 9 atom carbon spacer arm within the oligonucleotide chain.
- the modified oligonucleotides were purified by centrifuge filtration with OPC columns (ABI).
- Linker sequences were screened to ensure effective binding and to avoid repetitive sequences or unique sequences that may occur in targeted genomes. These linker sequences may also be designed with one or more 5' TA sites to facilitate psoralen crosslinking or with other sequences suitable for other crosslinking agents.
- linkers with a 5' terminal end were designed with an initial 5' TA sequence and synthesized with a C2 psoralen phosphoramidite at the 5' end. This modification ensures efficient crosslinking between linkers since it tethers a psoralen molecule to be exactly positioned at a potential crosslinking site.
- the modified oligomer In making Terminal TAG reporters by PCR, the modified oligomer only substitutes for one primer, such as Ml 3 forward, in which case, a standard Ml 3 reverse oligomer is used for the second primer. In making GENE-TAGs, the two modified oligomers substitute for both the forward and reverse primers.
- Figure 4A In addition to Ml 3 based inserts, a variety of other DNA templates and similarly modified primer pairs are suitable for making similar labeled reporter units of variable length.
- the COLOR-TAG design is based on the GENE-TAG method and reporter compositions, however it uses GENE-TAG reporters with different color or signaling labels to achieve probes with specific color signatures. See Figures 10,1 1, 12 and 13.
- this method created reporters with a solid color or with a mix of colors, that was sufficient to identify specific probes, by employing two or three generic GENE-TAG reporters of different color called COLOR-TAGs. These reporters are joined to each probe by virtue of an intermediate polynucleotide structure of multiple linkers, called a Multi- LINKER, that defined the mix and proportion of each COLOR-TAG that will bind.
- the Multi-LINKER contains one or more linkers, known as COLOR LINKERS, having a particular color acceptor sequence, which acceptor sequence is complementary to a COLOR-TAG bearing a particular colored label.
- linkers known as COLOR LINKERS
- color variations are achieved by changing the mix of linkers or the proportion of one linker type over another which comprise the Multi-LINKER.
- WRAP-PROBEs were employed, Multi-LINKER structures were affixed beforehand to the probe or added as an intermediate step before adding pre-made chains of reporters. After hybridizing such probes and linkers to their target sequence, the resulting complex becomes a molecular trap for a predicted mix of COLOR-TAGS that will define the underlying probe. In this manner, a variety of different probes were employed and differentiated at the same time.
- Multi-LINKERS Polynucleotide structures have been devised that provide one or more proximal linkers that bind to a probe component and two or more distal linkers that bind to a reporter element, such as GENE-TAGS. These interposed structures, known as Multi-LINKERS, greatly increase the signaling potential of a particular probe. Multi-LINKERS can take the form of single polynucleotides or a composite of two or more polynucleotides.
- the single polynucleotide form represents the most elemental Multi-LINKER, as depicted in Figure 14A. wherein a oligonucleotide has one proximal linker and two identical distal linkers on the same molecule.
- This elemental Mutli-LINKER has the minimal capacity to join two reporters to one probe.
- This elemental structure can also take a form wherein carbon spacers are introduced during synthesis, as depicted to the right of Figure 14A, so that greater flexibility is achieved and the binding sites are more accessible.
- These elemental Multi-LINKERs are based on the ready ability of commercial synthesizers to make long oligonucleotides.
- Composite polynucleotide Multi-LINKER structures have also been devised, comprising two or more polynucleotides. These composite polynucleotides are made of partially overlapping oligonucleotides, that are hybridized and crosslinked together, to create a complex of linkers joining one probe to two or more reporters. See FIG. 14B. These composite structures may be in branched or chain form.
- the chained multi-linker structure of the COLOR-TAG method is one such embodiment and this employs a few generic oligonucleotide components that partially overlap and that repeatedly link together in a linear array.
- Such chained multi-linker structures do not have an exact length and the number of repeated linker elements in the array is dependent upon the proportion of terminators provided when mixing the linker components together in hybridizing conditions. Since the intended chain length is created by ratio mixing, individuals chains formed in solution are expected to vary considerably, and the mix ratio employed, such as 4:1, simply provides an estimate of average length.
- the elemental Multi-LINKER structure shown in FIG. 14A provide a defined set of linker elements and thus bind a more predictable number of reporters.
- Multi-LINKERs are designed on the same principles employed in the present invention for joining probes and reporters together by their complementary linking sequences, generally called linkers. Namely, the sequences and polarity of the linkers are arranged so that they will generally pull on an end-to-end basis under typical hybridizing and wash conditions. Thus, if the probe linkers have 5' termini, the complementary Multi-LINKER proximal linker will also be 5', and the same alignment matching is employed with 3' linkers, or when the probe and reporter on the other end of the interposed Multi-LINKER differ in alignment. Furthermore, the lengths and compositions of the linker segments are constrained by any need to join elements together in situ versus situations where they can be prejoined or crosslinked.
- short segments of 10 to 20 bases are commonly used and these are generally designed with 3 to 5 dispersed sites containing 5' TA sequences to allow the incorporation of free psoralen and crosslinking with near UV (PUNA).
- PUNA near UV
- longer linker segments of 20 to 30 bases are generally employed where linker recognition must occur with sample D ⁇ A or R ⁇ A present and where crosslinking may not be employed or should be avoided.
- the longer linkers are still designed with approximately five 5 ' TA sites and both short and long linker sequences are designed with very similar GC content generally in the range of 45 to 65%. Linker sequences are also checked against known sequences expected in the target sample.
- Multi-LINKER components are generally designed to maximize short components up to 50 bases and to limit long components to about 80 bases.
- the composite Multi-LINKER depicted in FIG. 14B and 14C is designed as the simplest complex that can readily be achieved to reliably join a large number of GENE-TAGs, having 5' linkers, to probes with 5' ends such as the WRAP- PROBES of the present invention.
- the first unit (ONE-TO-FOUR) provides four fold amplification of short distal linkers and the second unit (ONE-TO-TWO) adds two fold amplification by providing 2 longer linkers per unit.
- ONE-TO-FOUR provides four fold amplification of short distal linkers
- ONE-TO-TWO adds two fold amplification by providing 2 longer linkers per unit.
- each end of the WRAP-PROBE will join about 8 GENE-TAGS to it via the Multi-LINKER with all components being aligned in a linear manner.
- layered GENE-TAGS with double distal linkers could also be used so that the second layer would bind another 16 GENE- TAGs to each probe end. Since two such layers could be readily applied, this embodiment would provide approximately 50 GENE-TAGS per probe.
- Multi-LINKERs can also provide multiple binding sites for other types of reporters, including short oligonucleotides that are prejoined to labeling agents either during synthesis, or by secondary chemistries, such as amine or thiol linkages. This latter method is particularly valuable when the labeling agents of interest are not readily incorporated into PCR generated GENE-TAGs or by enzymatically produced probes and reporters, such restricted label agents including but not limited to, certain metallic or fluorescent compounds, latex or magnetic beads, and bioluminescent agents such as aequorin.
- Figure 15 depicts an alternative embodiment wherein a multiplicity of short labeled oligomers are aligned 3' and attached beforehand without requiring a secondary hybridization step.
- This design provides four- fold times fourfold times four-fold amplification, thereby binding 64 such oligos with fluorescent compounds or other labels attached.
- This embodiment of the present invention could thus overcome the current difficult of labeling standard probes with fluorescent compounds such as Cy3 and Cy5 that only allow 1% incorporation by PCR or reverse transcriptase.
- Multi-LINKER embodiment represents an alternative to the chaining TINKER- TAG reporter system shown in Figure 16, which is similarly employed to cany pre-labeled short oligonucleotides, but which does not provide such precise quantitation of signaling.
- the invention further includes modified compositions and designs for improving the tethering of the probe and or the specificity of the detection.
- capture moieties are attached to the distal linker end of one probe; the dual probes are hybridized to the target strand and ligated together; the probe and target complex is fully denatured; and the ligated capture probe and reporters - joined via the ligation site - are captured and detected. See Figure 3A.
- This modification allows precise detection of mutations or base variations under liquid hybridization or near liquid hybridization conditions.
- an additional component devised of partially overlapping oligonucleotides creates an incipient ring structure by being joined to GAP-LOCK or WRAP-PROBE components prior to hybridization to the target.
- GAP-LOCK components attached to two ends of the RING-TAIL unit, a composite RING-LOCK probe is hybridized to the target, the ends are ligated together to form a closed loop, and reporters are joined to linkers on the RING-TAIL unit. See Figure 17.
- a similar RING-TAIL unit can be combined with WRAP-PROBE components to create a composite WRAP-LOCK probe.
- This composite probe provides an incipient ring structure that loops around the target and is closed by hybridizing an overlapping oligonucleotide. See Figure 18.
- the application of both of these probe methods creates a closed loop encircling the target strand, and at the same time, it supports the attachment of extended reporters such as arrays of GENE-TAG reporters. These modifications facilitate stringent washing or denaturation for more specific detection.
- the invention also includes a method for applying two such probes simultaneously to both the sense strand and the complementary antisense strand of a double- stranded DNA target in which the two probes have contrasting signaling. With this method, also known as the DOUBLE-LOCK design, the detection of a rare mutation or change can be confirmed by the detection of both signals at the same site. See Figure 19.
- the synthesis of the probe and reporter components of the present invention may be accomplished by conventional polymerase chain reaction (PCR) process.
- PCR polymerase chain reaction
- the protocol for PCR is set forth in Saiki et al., Science 230: 1350 (1985) and U.S. Pat. Nos. 4,683,195 and 4,683,202.
- a PCR adapter-linker method is set forth in Saunders et al. (1990); Johnson (1990) and PCT 90/00434.
- Another PCR method employing a mixture of primers is described in Meltzer et al., Nature - Genetics, 1 (1 ): 24-28 (April 1992).
- Probe and reporter components of the present invention are also synthesized by conventional means on a commercially available automated DNA synthesizer, e.g. an Applied Biosystems (Foster City, Calif.) model 380B, 392 or 394 DNA/RNA synthesizer.
- a commercially available automated DNA synthesizer e.g. an Applied Biosystems (Foster City, Calif.) model 380B, 392 or 394 DNA/RNA synthesizer.
- phosphoramidite chemistry is employed according to, e.g., Beaucage et al., Tetrahedron, 48:2223-2311 (1992); Molko et al, U.S. Pat. No. 4,980,460; Koster et al., U.S. Pat. No. 4,725,677; Caruthers et al., U.S. Pat. Nos.
- the probe has a nuclease resistant backbone.
- nuclease resistant backbone Many types of modified oligonucleotides are available that confer nuclease resistance, e.g. phosphorothioate, phosphorodithioate, phosphoramidate.
- phosphorothioates see, e.g., Stec et al., U.S. Pat. No. 5,151,510; Hirschbein, U.S. Pat. No. 5, 166,387; or Bergot, U.S. Pat. No. 5,183,885.
- modified oligonucleotides are synthesized with internal spacers, commonly composed of carbon chains, which separate different functional regions of the oligonucleotide.
- spacers commonly composed of carbon chains, which separate different functional regions of the oligonucleotide.
- the 5' end of such a spacer oligonucleotide will serve as a probe end or a reporter linker end while the 3' end serves as a primer for PCR amplification.
- the polymerase cannot jump across the spacer region of such an oligonucleotide and thus the probe or linker end beyond the spacer remains single stranded.
- the spacer between the probe and primer ends is a phosphorus linking group, which includes, but is not limited to, phosphodiester, methyl or ethyl phosphonate, phosphorothioate, phosphoramidate, hydroxyurethane, carboxyaminoalkyl, or carboxyaminoalkyl-phosphate linkers.
- spacers derived from phosphoramidite precursors such as the carbon chain Spacer Phosphoramidites C9 or C18 from Glen Research, Inc. (Sterling, Virginia), are preferred so that the modified oligonucleotides of the invention can be conveniently synthesized with commercial automated DNA synthesizers, e.g. Applied Biosystems, Inc. (Foster City, Calif.) model 394.
- Spacer length may vary significantly depending on the nature of the probe and primer sequence.
- spacer moieties are synthesized using conventional phosphoramidite and/or hydrogen phosphonate chemistries.
- phosphoramidite or hydrogen phosphonate monomers suitable for use in the present invention are set forth in Newton et al., Nucleic Acid Research, 21 :1155-1162 (1993); Griffin et al., J. Am. Chem.
- the preferred linking agent is a ligase, such as T4 DNA ligase, using well known procedures (Maniatis, T. in Molecular Cloning, Cold Spring Harbor Laboratory (1982)).
- Other DNA ligases are also suitable.
- T4 DNA ligase may also be used when the test substance is RNA [Engler, M.J. et al., The Enzymes, Vol. 15, pp. 16-17 (1982), Higgins, N. P. et al., Methods in Enzymology, Vol. 68, pp. 54-56 (1979)].
- Ligases from thermophihc organisms e.g. Tth DNA ligase, Gene, Vol. 109, pp.
- the linking agent may be a chemical agent which will cause the probes to link unless there is a nucleotide base pair mismatching at the target nucleotide position.
- T4 DNA ligase As the linking agent. This enzyme requires the presence of a phosphate group on the 5' end of one polynucleotide and a 3' OH group on the neighboring polynucleotide.
- Ligation conditions are adjusted so that ligation will occur if there is a base pair match at the target nucleotide position and will not occur if there is a mismatch at that position.
- the ligation may be performed at a temperature below the melting temperature of the annealed oligonucleotide probes.
- a suitable temperature for this purpose is about 5° C to about 30° C. below the melting temperature of the hybridized sequences.
- a suitable temperature is about 37° C for T4 DNA ligase.
- Factors that determine whether or not mismatching at the target nucleotide position can be determined, as detected by ligation include salt concentration and the amount of enzyme (ligase) used. Suitable salt concentrations range from 0 to 200 mM.
- the preferred cross linking agent is a bi- or tri-functional psoralen compound such as 4, 5', 8-trimethylpsoralen which intercalates the bases of hybridized DNA strands and causes covalent cross linking between them when treated with long wave ultraviolet light, preferably in the range of 312 to 360 nanometers.
- Site specific cross linking can also be facilitated by synthesizing an oligonucleotide probe component with a terminal psoralen molecule tethered by a carbon chain.
- Commercial reagents such as C2 psoralen and C6 psoralen from Glen Research, Inc.
- the reporter molecules of this invention can be labeled during PCR amplification in the presence of appropriately modified dNTPs, or they can be labeled after completion of the PCR reaction by chemical or enzymatic modification of the PCR products.
- the reporters are constructed of synthetic oligonucleotides, they can be labeled directly or indirectly by incorporating modified bases that either carry labeling agents or that provide chemical or immunological means for the attachment of labeling agents.
- such reporters may contain secondary linkers for binding short oligonucleotides that are conjugated to labeling agents - usually at one end.
- any of the various labeling techniques may be used to label reporters, including but not limited to fluorescent chemicals, radioactive materials, chemical haptens, or enzymatic modifiers. More than one label can be used.
- Preferred modified dNTPs include but are not limited to biotin-16-dUTP; digoxigenin-11-dUTP; biotin derivatives of dATP; fluoresceinated-dUTP; rhodamine labeled derivatives of dUTP or dCTP; hydroxy coumarin-labeled derivatives of dUTP; resorufin-1 l-2'-dUTP, and thiol or amine modified dNTPs, e.g.
- Amino-Modifier C6-dT Glen Research, Inc. (Sterling, Virginia).
- Other potential labels that may be attached or conjugated to reporter components include but are not limited to: (1) gold and silver particles; e.g. monomaleimido Nanogold, LI Silver, etc., Nanoprobes, Inc., (Stony Brook, NewYork); Colloidal Gold, Sigma Chemical Co. (Saint Louis, Missouri); (2) chemiluminescent or bioluminescent molecules such as aequorin, e.g. Aqualite, Sealite Sciences, Inc., (Norcross, Georgia); and (3) agents which can provide Raman spectrometry signaling such as DNA and histological dyes; e.g.
- Gold and silver labeling is of particular interest for the TINKER-TAG reporter system wherein gold particles, e.g. monomaleimido Nanogold, Nanoprobes, Inc., (Stony Brook, New York), can be conjugated to oligonucleotides that bind to the side arms of the reporters and then silver ions, e.g. LI Silver, Nanoprobes, Inc., (Stony Brook, New York), can be added to precipitate large clusters of silver of 30 to 100 nm around the gold seeds forming dense masses suitable for light microscopy visualization. The size of the cluster may vary with the size of the gold particle.
- This reporter variation also known as the GOLD-TAG method, provides the advantage of avoiding the safety, expense and equipment requirements of radioactive or fluorescent labeling. See Figure 20.
- Bioluminescent immunoassays using the photoprotein aequorin have attained sensitivity in the zeptomole range (10 ⁇ 21 mo l) which is at least 10 ⁇ times more sensitive than chemiluminescent enzyme immunoassays in widespread use.
- the bioengineered aequorin contains three calcium binding sites and, upon addition of calcium ions, undergoes a conformational change that catalyzes the oxidation of a bound coelenterazine producing a brief flash of blue light that peaks in 0.3 seconds, centered at 469 nm.
- biotinylated PCR amplicons of the target nucleotide sequence are captured in streptavidin-coated microtiter plate wells, and detected with probes and reporters labeled with digoxigenin.e.g., dig-11-dUTP. These digoxygenin haptens then bind a stable, covalent conjugate between the aequorin photoprotein and the sheep anti-digoxigenin Fab fragment. When stimulated by calcium, the amount of light produced is directly proportional to the amount of digoxigenin detected.
- aequorin molecules can be directly conjugated to the 5' end of simple oligonucleotides that can be secondarily linked to probe and reporter units of the present invention such as the TINKER-TAG constructs.
- the use of said aequorin conjugated oligonucleotides as labeling for TINKER-TAG reporters is expected to enhance bioluminescent signal detection in microwell formats while maintaining the advantages over competing technologies in sensitivity, low background, stability, and simplicity of assay design. See Figure 16.
- the staining intensity achieved using the reporters may be amplified with a variety of systems, including but not limited to fluorochrome conjugated avidin and/or labeled antibodies. Similarly, other known detection schemes such as labeling of probe molecules with enzymes, sulfur or mercury may be applied in order to suit special experimental conditions. DNA can be counterstained with DNA-specific dyes, including but not limited to DAPI, that fluoresce in different wavelength intervals dependent on the selected scheme for visualization of bound probe molecules.
- Such modified nucleotides can provide multiple signaling sites by incorporating them along the length of the reporter molecule or at the ends of attached oligonucleotides.
- a 5' phosphate group can be introduced as a radioisotope by using polynucleotide kinase and gamma 32 P-ATP to provide a reporter group.
- Biotin can be added to the 5' end by reacting an aminothymidine residue, or a 6-amino hexyl residue, introduced during synthesis, with an N-hydroxysuccinimide ester of biotin. Labels at the 3' terminus may employ polynucleotide terminal transferase to add the desired moiety, such as for example, cordycepin 35 S-dATP, and biotinylated dUTP.
- the present invention generally combines WRAP-PROBE or GAP-LOCK probe designs, and various manifestations thereof, with the GENE-TAG or COLOR-TAG signal amplificaton systems.
- these probe designs could be employed in combination with other commercial probe and signaling systems such as the dendrimers of Polyprobe, Inc. (Media, Penn.) [U.S. Pat. No. 5,487,973] and the branch DNA (bDNA) components of Chiron Corp. (Emeryville, Calif.) [U.S. patent 5,124,246]. See Figure 21A.
- the Chiron products are designed to detect a gene by creating a series of unique oligonucleotide probes which bind in part to the target sequences and which have singular generic tails that bind to the bDNA structures. Because this system relies on simple hybridization to hold down the synthetic bDNA signaling structures, effective gene detection requires multiple probes targeting multiple locations along a gene. However, the substitution of a GAP-LOCK or WRAP-PROBE element instead of a simple tailed oligonucleotide probe would provide a wrapped structural configuration that greatly exceeds the forces of hybridization, and which would support, at the least, two times the bDNA signal structure of their current probes.
- the dendrimers of Polyprobe also rely on simple hybridization to bind the large signaling structure to the target - generally by binding the target sequence with one of the multiple single stranded a ⁇ ns that protrude from the outer layer.
- the WRAP-PROBE or GAP-LOCK probes could be employed very effectively, in combination with these dendrimers, to either bind larger dendrimers or to bind them more durably and or more specifically to the target.
- the probes of the present invention can be employed as diagnostic probes to detect the presence of one or more target polynucleotides in a wide range of samples, including diagnostic applications of nucleic acid probes in human diagnostics, forensics, and genetic analysis. See, e.g., Caskey, Science 236: 1223-1228 (1987); Landegren et al. Science, 242:229 237 (1988); and Arnheim et al., Ann. Rev. Biochem., 61:131-156 (1992).
- Other uses for the DNA molecular diagnostic devices of the present invention include environmental samples, e.g.
- probes and reporter systems can be readily employed in a variety of membrane formats such as dot blots, slot blots, Southern and Northern blots, and expression microarrays; in gels such as agar or polyacrylamide; in a variety of in situ formats such as for FISH (fluorescent in situ hybridization) to map genes on chromosomes or for in situ detection of RNA transcripts or genes in sectioned tissue and/or tissue microarrays; in microwell plates to detect infectious organisms or unbound DNA fragments extracted from bodily fluids or wastes; and in various solid substrate chip formats to detect genes, mutations or mRNA including, but not limited to, oligonucleotide microarrays, cDNA microarrays, and molecular detection chips employing flourescence, optical interferometry, Raman spectrometry or semiconductor electronics.
- membrane formats such as dot blots, slot blots, Southern and Northern blots, and expression microarrays
- gels such as a
- Example 1 GAP-LOCK Probe Method The present example demonstrates the application of the GAP-LOCK dual probe mechanism to detect a critical Mycobacterium tuberculosis (MTB) sequence which is diagnostic of that infectious agent.
- Special components for the two GAP-LOCK probe units were made on an ABI 394 automated synthesizer by synthesizing three modified oligomers with two C9 internal spacers (nine carbon phosphoramidite products made by Glen Research, Sterling, Virginia). (In all sequence descriptions below a C9 spacer is shown as "9" to avoid confusion with cytidine bases [C].) Of these modified oligomers, two of them had M13 forward sequences on their 3' end to serve as a primer for PCR amplification.
- MTB Mycobacterium tuberculosis
- the 5' First Probe Oligo (FP) (SEQ ID NO: 1,2)
- the other one called the Reversing Linker Oligomer (SEQ ID NO: 6,7)
- the third modified oligomer (RP) (SEQ ID NO: 4,5)
- RP Reverse Probe Oligo
- C9 spacers is optional for the 3' Reverse Probe Oligo.
- the annealed oligos were crosslinked together with psoralen plus UV, using 3 ⁇ g/ ⁇ l psoralen (4,5',8-trimethylpsoralen) for 15 minutes, and secondly exposing the samples to 15 minutes of long wave UV (312nm) in clear micro fuge tubes while placed on a UV light box.
- Psoralen preferentially intercalates and crosslinks at 5' TA sites.
- Additional gel shift experiments were conducted with crosslinked probe components wherein the linker sequence contained only one 5' TA site vs. five 5' TA sites. Such crosslinking appears efficient since it was found that both complexes remained intact and were equally resistant to 10 minutes of 0.05 M NaOH treatment.
- the primary target DNA was a known amplified 600 bp fragment of the 16s ribosomal gene of Mycobacterium tuberculosis. Negative control DNA samples were amplified from a similar-sized but sequence-unrelated fragment of the bombesin receptor gene. In all dot blot experiments, solutions of the target DNAs were applied in 1 ⁇ l aliquots to nylon membranes in multiple 40 ng dots or in a series of 50% dilutions starting with 40 ng of DNA in the first dot. The DNA was denatured with 0.5 M NaOH and neutralized with 5xSSC and 0.1% SDS solution.
- the denatured target DNAs was crosslinked to the membranes by exposing them to 2000 mJ of 253 nm UV in a UV crosslinker. Hybridizations were perfo ⁇ ned at 42°C in a rotary apparatus running at approximately 10 rotations per min. The membranes were transferred to individual roller tubes, pretreated in the apparatus for 2 hours with hybridization buffer (5xSSC, 1% SDS, 5xDenhart's, lxBackground Quencher) before the probe sample was added and hybridization was continued. Unlike standard DNA probes, the probe and reporter units were not denatured. After hybridization, the blots were washed for 30 min in 5xSSC/0.5% SDS at
- the First Probe (FP) and the Reverse Probe (RP) with reporters attached were added for hybridization overnight (14 to 18 hrs).
- One set of four strips were treated with probes with reporter templates of about 300 bp while the other set of four strips were treated with probes with reporter templates of about 800 bp.
- the first strip in each set of four used only the First Probe (FP).
- the second strip in each set of four used only the Reverse Probe (RP).
- the third and fourth strip in each set used both the First Probe and the Reverse Probe (F/R), however, only the fourth strip was treated for ligation (F/R +Lig).
- T4 kinase at 37°C for 30 min, to phosphorylate the 5' half-probe end, and with T4 ligase at
- the strips were read with the phosphor imager.
- the strips were then treated for 5 minutes with dilute alkali (0.05 M NaOH), neutralized, and rinsed to denature and release any unligated probe and reporter units. These washed, second half-blot strips were then read on the phosphor imager and compared to the first half-blot strips.
- First Probe Fabrication Synthesize Oligomers A and B. Using Oligomers A and B as primers, run a PCR reaction using an Ml 3 DNA template (300 or 800 bp in length) to produce a long double stranded reporter with a single stranded half-probe on one end.
- Reverse Probe Fabrication Synthesize Oligomers D, C and E. Using Oligomers D and E as primers and a Ml 3 DNA template of 300 or 800 bp, run a PCR reaction to produce a long double stranded generic reporter TAG with a single stranded linker on one end. Oligomer C is then joined to the generic TAG unit via the generic linker sequences thereby adding a single stranded half-probe with a 3' end. The Oligomer C can be crosslinked to the generic reporter TAG unit using free psoralen plus UV light.
- Target-Specific Oligomer (SEQ ID NO: 8)
- Sequence A was joined to Sequence B via complementary 2nd linker sequences and then they were covalently crosslinked together via three internal TA sites using free psoralen plus UN treatment.
- ten femtograms of template D ⁇ A from any phage were incubated with 0.5 U Taq polymerase, 100 mM d ⁇ TP, 20 inM of labeled dUTP or dATP, standard PCR buffer with 4.0 mM magnesium chloride, and 0.2 mM of each primer or modified oligomer in a 100 ml volume.
- the signaling nucleotide was labeled with digoxigenin or 32p. The labeling ratio was 1 :3 (labeled vs. unlabeled).
- Other labeling haptens such as biotin, fluorescein (FITC) or dinitrophenol are also suitable.
- GE ⁇ E-TAGs and Terminal TAGs were pre-formed as reporter chains of statistically defined length by premixing them together in defined proportions under annealing conditions. If a 3:1 mix of GE ⁇ E-TAGs to Terminal TAGs is made, most chains will consist of 4 units, many will contain 2 or 5 units, and only a few will have 1 unit or 6 or more units. In most experiments, GE ⁇ E-TAGs/Terminal TAG pre-mixes ranging from 1 : 1 to 8: 1 were used. In some experiments, only Terminal TAGs or only GE ⁇ E-TAGs were used.
- Oligomers A and B serve as primers in a PCR reaction using a M13 DNA template 800 bp long. 32p_ ⁇ aDe ⁇ e( j TTP bases are incorporated during PCR producing a long double stranded reporter with single stranded linkers on each end.
- Terminal TAG fabrication Oligomers C and D serve as primers in a PCR reaction using an Ml 3 DNA template 300 bp long. 32p_ ⁇ aDe ⁇ e( ⁇ dTTP bases are incorporated during PCR producing a long double stranded reporter with a single stranded linker on one end. In some experiments, ( Figure 5A2) the Terminal TAGs were not labeled and were just used to end a chain of GENE-TAGs.
- TERMINATOR (used instead of Terminal TAG): TAGACCTAGGGGTAGCTAGGCTAC (SEQ ID NO: 17)
- WRAP-PROBE Detection with nylon membrane DNA dot blots The ability of 32 P-labeled WRAP-PROBEs to specifically hybridize and label nucleic acids were tested with serial dot blots of MTB target DNA using the same methods employed in Example 1 above with respect to: preparing dot blots of target and control DNAs on nylon membrane supports; prehybridizing treatment; hybridizing probes and reporters in a rotary apparatus at 42°C; the composition and use of hybridization and wash buffers; and reading labeling with a phosphor imager.
- the TAGs were mixed in the following ratios of GENE-TAGs to Terminal TAGs: 1 :1, 2: 1, 8: 1.
- the WRAP-PROBE was applied for 14 hrs, the TAG mixture was added for 4 hours, and after washing, the samples were read with a phosphor imager.
- Fig. 5 A. [A2] the TAG ratios were changed to 1 : 1, 2: 1 and 4: 1 and
- Target-Specific Oligomer (SEQ ID NO: 18)
- Terminator (SEQ ID NO: 23) 5' CTAGACCTAGGGGTAGCTAGGCTAC
- Labeling molecules include but are not limited to aequorin, enzymatic catalysts, fluorochromes, dyes and metallic particles.
- Probe Components (targeting sense strand of MTB 16s RNA sequences)
- RING-TAIL components may be prepared in bulk. Combine and covalently join equimolor proportions of A to E by standard hybridization and crosslink methods to form RING-LOCK unit. Using methods described in Examples 2-5, manufacture GENE-TAG reporters or other reporters with linkers complementary to the RING-TAIL unit. See Figure 17.
- target sample hybridize and ligate RING-LOCK unit to target, denature or wash stringently, hybridize reporters and detect target mutation or sequence variation.
- Target-Specific Oligomer (SEQ ID NO: 31)
- RING-TAIL components (B and C) and LOCK component (D) may be prepared in bulk. Combine and covalently join equimolor proportions of A, B and C components by standard hybridization and crosslink methods to form WRAP-LOCK unit. Using methods described in Examples 2-5, manufacture GENE-TAG reporters or other reporters with linkers complementary to the RING-TAIL unit. See Figure 18.
- target sample hybridize WRAP- LOCK unit to target.
- Complex of probe and LOCK component may be treated with psoralen plus UV to form covalently closed circle. Wash stringently, hybridize reporters and detect target sequence.
- First Probe Components (targeting sense strand of MTB 16s RNA sequences)
- Second Probe Components (targeting antisense strand of MTB 16s RNA sequences)
- Type 1 and Type 2 RING-TAIL components are prepared in bulk. Combine and covalently join equimolor proportions of A to E by standard hybridization and crosslink methods to form Type 1 sense strand RING-LOCK unit. Separately, combine and covalently join equimolor proportions of F to J by standard hybridization and crosslink methods to form Type 2 antisense strand RING-LOCK unit. Using methods described in Examples 2-5, manufacture two Types of GENE-TAG reporters or other reporters with linkers complementary to either the Type 1 or Type 2 RING-TAIL unit. See Figure 19.
- Example 9 Using methods described in Examples 1-6, prepare denatured target sample, hybridize and ligate Type 1 and Type 2 RING-LOCK units to target. Denature or wash stringently, hybridize Type 1 and Type 2 reporters, and detect target mutation or sequence variation with detection preference given to sites containing both Type 1 and Type 2 signaling.
- Example 9 Using methods described in Examples 1-6, prepare denatured target sample, hybridize and ligate Type 1 and Type 2 RING-LOCK units to target. Denature or wash stringently, hybridize Type 1 and Type 2 reporters, and detect target mutation or sequence variation with detection preference given to sites containing both Type 1 and Type 2 signaling.
- Example 9 Using methods described in Examples 1-6, prepare denatured target sample, hybridize and ligate Type 1 and Type 2 RING-LOCK units to target. Denature or wash stringently, hybridize Type 1 and Type 2 reporters, and detect target mutation or sequence variation with detection preference given to sites containing both Type 1 and Type 2 signaling.
- Bioluminescent detection of MTB target DNA Biotinylated PCR target product was denatured for 5 min (1 M NaOH, 200 mM EDTA), neutralized (0.15 M Na2HPO4 ; pH 6.0), and added to streptavidin-coated microtiterplates, containing 2 ng digoxigenin-labeled GAP- LOCK first probes (see below) in 100 ⁇ l hybridization buffer (62.5 mM Na2HPO4, 0.94 M NaCl, 94 mM citric acid, 10 mM MgC12, 0.125% Tween-20, 0.0625% BSA, 15 mM NaN3, pH 6.5) (final concentration equal to 5.5x SSC).
- Hybridization at 42°C for 2 hrs was followed by washing with wash buffer.
- Anti-digoxigenin aequorin conjugate (5 ng in 100 ⁇ l) was added for 30 min followed by detection measuring enhanced flash (469 nm) on a luminometer using a calcium trigger solution (50 mM Tris, 10 mM calcium acetate, pH 7.5, 15 mM NaN3).
- the limit of detection for the luminometer was previously determined empirically at 2.1x10 " 1 moles.
- Oligomers A and B were synthesized. Using Oligomers A and B as primers, a PCR reaction was run using an arbitrary M13 DNA template (300 bp in length) to produce a long double-stranded reporter containing digoxigenin (1 :3 ratio) with a single-stranded probe on the 5' end.
- the probe was hybridized to denatured, biotinylated target DNA, captured on the surface of the wells.
- Anti-dig aequorin (Sealite Sciences, Inc. Norcross, GA) was added; the microtiter plate was put in a luminometer; calcium was added to trigger aequorin; and detection levels were recorded.
- the results in Figure 2 IB show highly sensitive detection.
- Probe Components (targeting sense strand of MTB 16s RNA sequences)
- Terminator (SEQ ID NO: 60) 5' CTAGACCTAGGGGTAGCTAGGCTAC Using methods described in Examples 1-9, synthesize oligonucleotides D, E, F and G. Hybridize and crosslink multiple D and E subunits together to form linear TINKER-TAG chains, length limited by the addition of a small ratio (e.g. 1 :6) of Terminators (G subunit). See Figure 6.
- the GAP-LOCK Reporter Probe Subunits can be added and crosslinked to the TINKER TAG units at this stage. See Figure 16.
- the Label Subunits (F) conjugated with aequorin will not be added to the linker side a ⁇ ns of the TINKER TAGs at this step.
- TINKER TAG units may be preattached to the Reporter Probe Subunit. Ligate the Probe Subunits together and transfer sample to capture-ready mictrotiter plates coated with stre avi din. Denature and wash to remove unligated Reporter Probe Subunits and released target strands. Add Aequorin Label Subunits to link to side amis of TINKER TAGs bound to captured probe complex. Wash to remove unlinked Aequorin Label Subunits. Transfer plate to luminometer and record detection by triggering aequorin flash with calcium stimulation.
- the method should detect and disctinguish 16s MTB RNA sequences (common TB) from Mycobacterium avium sequences (the AIDS prevalent TB) which differ from the MTB target sequences by 4 bases in the nucleotides immediately adjacent to the GAP-LOCK probe ligation site that is employed.
- GAP-LOCK First Probe Method with FISH detection GAP-LOCK First Probes for FISH detection were created with digoxigenins (dig-11- dUTP) incorporated in the attached reporter tail (1 :3 substitution ratio for thymidine bases) to target a chromosome 12 specific site adjacent to the centromere which has multiple tandem repeat elements. Because unligated GAP-LOCK First Probes with long reporter tails are labile, probes for FISH detection were constructed with a short reporter tail of 300 bp and a large 30 bp probe "footprint" of target specific sequences.
- BLAST analysis of the 30 mer sequences against the GenBank libraries show two published fragments (171 and 685 bp) with single sites with a 100% match, and when including another two published fragments (340 and 1359 bp), a total of five other sites match the First Probe sequences with homologies of 82% to 96%.
- the probe was hybridized to the chromosome target at 37°C for 14 hours, washed and treated with anti-digoxigenin FITC stain and propidium iodide counterstain by standard methods as described above.
- the following methods apply to the WRAP-PROBE and COLOR-TAG methods in the FISH format using human chromosome and nuclei preparations to detect and map the ABR gene and the 15-LO-l gene on the short a ⁇ n of Chromosome 17 with respect to the microsatellite marker D17S379 on the same chromosome.
- a control probe of similar design is also provided to detect and map the repetitive subcentromeric site on Chromosome 12 which was previously mapped with the GAP-LOCK First Probe method described in Example 11 above.
- the oligonucleotides described include all components needed for preparing WRAP-PROBEs and COLOR-LINKER chains for the four target sites, as well as all components required to make four different COLOR-TAG reporters as needed to provide mixed three-color detection. However, to distinguish these sites, only two color reporters need be made, and so this example will only use RED and GREEN COLOR-TAGs. Red labeling is provided by anti-biotin rhodamine fluorescence. Green labeling is provided by anti-digoxygenin FITC or fluorescein.
- the ABR probe is designed to only attract RED COLOR-TAGs, the 15-LO-l probe only attracts GREEN COLOR-TAGs, and both the D17S379 probe and the Chromosome 12 site probe attracts a mix of half RED and half GREEN COLOR-TAGs.
- FISH detection the green fluorescent compound, FITC or fluorescein, actually gives a yellow green color, and the mixed color probes will give a yellow orange color.
- FITC or fluorescein actually gives a yellow green color
- the mixed color probes will give a yellow orange color.
- a 2 CHR-17: 15-LO-l gene: (SEQ ID NO: 62)
- a 3 CHR-17: D17S379 microsatellite marker: (SEQ ID NO: 63)
- a 4 CHR-12 subcentromere site: (SEQ ID NO: 64)
- G Generic Chain Terminator: (SEQ ID NO: 70) 5' ATAGGGTTAGCCTAC
- RED GENE-TAG Oligonucleotides (SEQ ID NO: 71,72) H: Proximal Spacer Oligomer with two 9 carbon spacers: (creates proximal linker)
- Distal Spacer Oligomer with two 9 carbon spacers (creates distal linker) (SEQ ID NO:
- Probe assembly Using methods described in Examples 1, 2-4 and 11, synthesize above oligonucleotides A to P and purify. Construct WRAP-PROBEs separately by mixing equimolar portions of Target Specific Oligomer and Reversing Linker Oligomers in separate tubes in PCR buffer at 42°C for 10 min as follows: For ABR gene probe: 1 : 1 ratio ABR Target Specific Oligomer (Al) with Reversing Linker (B) For 15-LO-l gene probe: 1 :1 ratio 15-LO-l Target Specific Oligomer (A2) with Reversing Linker (B)For D17S379 marker probe: 1 :1 ratio D17S379 Target Specific Oligomer (A3) with Reversing Linker (B) For CHR-12 site probe: 1 :1 ratio CHR-12 Target Specific Oligomer (A4) with Reversing Linker (B)
- Each WRAP-PROBE should therefore have approximately eight GENE-TAG acceptor sites on each Chain extending from the terminal ends of the probe, for a total of about sixteen such sites per probe.
- the total length of the probe with two Chains should be less that 900 bases.
- RED Reporter Amplification and Hapten Labeling Generate RED reporters by PCR using 2 ⁇ l RED Forward Primer with spacers, 2 ⁇ l RED Reverse Primer, 2 ⁇ l Ml 3 template (300 bp), and incorporate biotin- 16-dUTP in ratio: 1 biotinylated base per 3 thymidine bases. Purify reporters with Microcon 100 micro fuge columns.
- GREEN Reporter Amplification and Hapten Labeling Generate GREEN reporters by PCR using 2 ⁇ l GREEN Forward Primer with spacers, 2 ⁇ l GREEN Reverse Primer, 2 ⁇ l M13 template (300 bp), and incorporate digoxyigenin-11-dUTP in ratio: 1 biotinylated base per 3 thymidine bases. Purify reporters with Microcon 100 microfuge columns.
- RED COLOR-TAGs with RED Terminator molecules RED Terminator molecules
- GREEN COLOR-TAGs with GREEN Terminator molecules in PCR buffer at 47oC for 20 min, using different molar ratios as needed for signaling. Start with 3:1 ratio; progress to 10:1 ratio if required.
- Lymphocyte cultures are grown by standard cytogenetic methods using PHA stimulation and colchicine mitotic arrest to harvest metaphase cells. Cells are swollen by KCl hypotonic and fixed with 3:1 methanol/acetic acid.
- hybridization mixture For each slide, 10 to 25 microliters of hybridization mixture is used containing 20 ng of the WRAP-PROBEs, 20 to 40% formamide, 5 to 10% dextran sulfate, 2xSSC, 0.1% SDS, 5xDenhart's solution, IxBackground Quencher (MRC) and 40 mM sodium phosphate.
- In situ hybridization is maintained at 37o to 42o C in a humidified chamber. Probe hybridization is tested in the range of 2 to 6 hours.
- COLOR-TAG reporter hybridization is tested at 4 to 8 hours, but up to 18 hours if needed. Adjustments in formamide concentration and temperature are essential for optimizing FISH. Denaturing the double-stranded COLOR- TAG reporters prior to or during hybridization is avoided.
- GENE-TAGs were created that could stack on one another end to end but that would not form chains in solution when kept separately. See Figure 7A. These alternating GENE- TAGs were constructed by using the modified spacer primers that were previously employed in Example 12 above to create GREEN and RED COLOR-TAGs for the COLOR-TAG system.
- the PCR primer pairs for the reporter template were switched by combining the Proximal Spacer Oligomer of the RED COLOR-TAGs and the Distal Spacer Oligomer of the GREEN COLOR-TAG units to make Type I GENE-TAGs, and conversely the Proximal Spacer Oligomer of the GREEN COLOR-TAGs was combined with the Distal Spacer Oligomer of the RED COLOR-TAG units to make Type II GENE-TAGs.
- a WRAP-PROBE or other probe provided linkers for joining RED COLOR-TAGs, Type I COLOR-TAGs could be applied.
- this Type I reporter has GREEN linker sequences, only one such COLOR- TAG would bind to each probe forming a single layer of GENE-TAGs on a group of bound probes. Then following this step, with a wash step in between, a Type II GENE-TAG could be similarly applied, to form a second layer, since this GENE-TAG would bind to the distal termini of the prior Type I layer.
- Duo GENE-TAG fabrication Using methods described in Examples 1, 2, 4, 6, 7 and 12, synthesize oligonucleotides A, B, C and D. Oligomer set A and B and oligomer set C and D serve as primers in two separate PCR reactions using a Ml 3 DNA template 600 bp long to create Type I and Type II GENE-TAGs. Radioactive P32 is incorporated in 1 :3 thymidine bases during PCR.
- Radioactive labeling is then read with a phosphoimager for 2 to 4 hours or with x-ray film exposure for 6 to 18 hours.
- This layered application of Type I and Type II GENE-TAGs was employed and compared to the use of standard GENE-TAGs joined in chains.
- the spacer primer set to make RED GENE-TAGs was employed to make P32 labeled standard GENE-TAGs and these products were mixed with a terminator oligomer on a 3:1 basis to produce chains averaging three GENE-TAGs long.
- the Type I and Type II GENE-TAGs were made at the same time and they were labeled by the same protocol as described above.
- Nylon membranes were prepared with slot blot depositions of 10" copies of the target DNA, 15-LO-l, a control DNA, TNF a, and a second control sample such as sterile water.
- WRAP probes containing a 257 bp sequence of 15-LO-l cDNA were prepared with a biotinylated primer containing overlap linker sequences and with oligonucleotide adapters containing a terminal GENE-TAG Linker sequence corresponding to that of the RED COLOR-TAGs or to the proximal linker of the Type I GENE-TAGs.
- the probe was hybridized overnight at 48 degrees C, washed and then either the 3:1 chain of standard GENE-TAGs or a Type I GENE-TAG was applied to each sample in a roller hybridization apparatus at 42 degrees C.
- the chain of standard GENE-TAGs was hybridized to the probe complex for 6 hours and detection was accomplished with x-ray film. See Figure 8A.
- three samples were prepared for each concentration and treated separately. In the first sample, the Type I GENE-TAGs were hybridized for 2 hours, then washed and layered with Type II GENE-TAGs for another two hours, followed by a third treatment for two hours with Type I GENE-TAGs.
- Type I and Type II GENE-TAG reporters of Example 13 were additionally created with double distal linkers in tandem so that signaling could be doubled with each layer that is applied. See Figure 9.
- This method applies the Type I and the Type II GENE-TAGs in sequential manner using the same methods and procedures of Example 13 except that the following modified spacer oligomers are employed in manufacturing Type 1 and Type II GENE-TAGs with double distal linkers.
- Double Distal Spacer Oligomer with two 9 carbon spacers (creates double distal linker) (SEQ ID NO. 96,97,98)
- Double Distal Spacer Oligomer with two 9 carbon spacers (creates double distal linker) (SEQ ID NO. 101,102,103)
- Two-Part GENE-TAG Multi-LINKER In order to provide branching linkers for the binding of multiple GENE-TAGs to a WRAP -PROBE, GAP-LOCK probe or other probes affixed with complementary linkers, a set of Two Part Multi-LINKERs were created. These multi-linkers were designed so that both the first linker to be joined to the probe and the multiple terminal distal linkers to be joined to the GENE-TAGs have sufficient length and sequence exclusivity to join these components durably and reliably in an in situ situation, that is where the probe and target have been hybridized together in a detection format and diverse non-target nucleotide sequences may be available in the target sample. In addition, the first and distal linkers of the composite Two-Part Multi-LINKER have the capacity to be crosslinked to either the probe or to GENE-TAGs either before application or afterwards.
- Second Component One to Two Multi-Linker (SEQ ID NO. 109,110,111) 5' GCCTAGACCTAGGGGTAGCTAGGCTAC-99- GCCTAGACCTAGGGGTAGCTAGGCTAC-99-GTACGCTATTAC
- the Multi-LINKER components are hybridized together in vitro with a molar ratio of the second components that is at least four times the molar quantity of the first component using the methods described in Example 12 above. If the probe and Multi-LINKER are to be crosslinked together, these components are mixed together under the same hybridizing conditions and the crosslinking of all components with psoralen and UV is performed in a single step rather than sequentially since a second hit with UV may break the covalent bonds established previously.
- Three-Part Oligo-TAG Multi-LINKER In order to provide branching Multi-Linkers for the binding of multiple short labeled oligonucleotides, called Oligo-TAGs, to a WRAP-PROBE, GAP-LOCK probe or other probes affixed with complementary linkers, a set of Three-Part Multi-LINKERs were manufactured. These multi-linkers were designed so that the first linker to be joined to the probe has sufficient length and sequence exclusivity to join these components durably and reliably in an in situ situation, that is where the probe and target have been hybridized together in a detection format and diverse non-target nucleotides may be available in the target sample. In addition, the first linker of the composite Three-Part Multi-LINKER may be crosslinked to the linker of the probe.
- Three-Part Multi-LINKERs were also designed in two sets so that comparative labeling could be employed where one probe would have the capacity to bind or would be prebound to the first multi-linker set and where a second probe would have the capacity to bind or would be prebound to the second multi-linker set.
- This particular two set example was designed and made to bind labeled oligonucleotides with the fluorescent compounds Cy3 and Cy5 which are commonly employed in comparative hybridizations with DNA chip technologies and FISH protocols.
- the Cy3 and Cy5 components are commercially available in phosphoramidite form allowing them to be easily added to the 5' end of an oligonucleotide duringsynthesis using common commercial synthesizers.
- the Multi-LINKER components of each set are hybridized together in vitro with a molar ratio of the second components that is at least four times the molar quantity of the first component, and with the molar ratio of the third components that is at least four times the molar quantity of the second component, using the methods described in Example 12 and 15 above. If the probe and Multi-LINKER are to be crosslinked together, these components are mixed together under the same hybridizing conditions, and the crosslinking of all components with psoralen and UV is performed in a single step rather than sequentially as described in Examples 12 and 16 above.
- two WRAP-PROBEs are made to each target sequence one being complementary to the sense strand and the other being complementary to the antisense strand.
- the two WRAP-PROBEs are made with different linker sequences as described in Examples 8 above for DOUBLE-LOCK probes in order to bind different reporters such as the RED and GREEN GENE-TAGs of Example 12 above, and they are applied and detected in the same manner using the FISH protocols described in Example 12 .
- the example is for a pair of Double- WRAP FISH PROBEs for the promoter region of the 15-LO-l gene on Chromosome 17.
- WRAP-PROBEs CHR-17: 15-LO-l gene (SEQ ID NO. 143) Sense Target Oligomer:
- Anti-Sense Target Oligomer (SEQ ID NO. 145)
- the RED and GREEN GENE-TAGs may be applied in linear chains or branching chains using double distal linkers as described in Example 14 above.
- the protocols of Examples 8 and 12 are used to detect the two colored reporters separately and thus confirm a valid target detection.
- the present invention relates generally to a modular method of integrating different gene probe methods and reporter methods for biological research and diagnostics by designing a set of nucleic acid probe compositions and a set of related reporter compositions that can be interchanged and joined together, either directly or indirectly.
- the present invention consists in part of the design and employment of common sets of artificial complementary nucleotide linker sequences that can join, align or multiplex different probe and reporter units together in a functional and versatile manner.
- the present invention consists in part of the design and employment of an additional set of interconnecting polynucleotide compositions, known as multilinkers, that similarly join, align, amplify or bring into functional association the aforesaid probe and reporter compositions by virtue of designing and making said multilinkers with sets of nucleotide sequences that allow partial or complete self assembly and that correspond in whole or in part to the common linker sets of the probe and reporter compositions of the present invention.
- the present invention also consists in part of the future probe and reporter compositions and methods that may herewith be created by virtue of employing the modular design principles of the present invention, or by employing the same or similar linker sets and multilinker compositions that are herein embodied.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99934134A EP1112378A1 (en) | 1998-07-17 | 1999-07-16 | Methods for detecting and mapping genes, mutations and variant polynucleotide sequences |
CA002335324A CA2335324A1 (en) | 1998-07-17 | 1999-07-16 | Methods for detecting and mapping genes, mutations and variant polynucleotide sequences |
AU50032/99A AU5003299A (en) | 1998-07-17 | 1999-07-16 | Methods for detecting and mapping genes, mutations and variant polynucleotide sequences |
US12/334,036 US20090275029A1 (en) | 1999-07-16 | 2008-12-12 | Systems and Methods to Quantify and Amplify Both Signaling and Probes for CDNA Chips and Gene Expression Microarrays |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9321998P | 1998-07-17 | 1998-07-17 | |
US60/093,219 | 1998-07-17 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/007508 Continuation-In-Part WO2001066802A1 (en) | 1999-07-16 | 2001-03-09 | SYSTEMS AND METHODS TO QUANTIFY AND AMPLIFY BOTH SIGNALING AND PROBES FOR cDNA CHIPS AND GENES EXPRESSION MICROARRAYS |
US10/380,596 Continuation-In-Part US7482443B2 (en) | 1999-07-16 | 2001-03-09 | Systems and methods to quantify and amplify both signaling probes for cDNA chips and genes expression microarrays |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000004192A1 true WO2000004192A1 (en) | 2000-01-27 |
WO2000004192A8 WO2000004192A8 (en) | 2000-07-13 |
Family
ID=22237801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/016242 WO2000004192A1 (en) | 1998-07-17 | 1999-07-16 | Methods for detecting and mapping genes, mutations and variant polynucleotide sequences |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1112378A1 (en) |
AU (1) | AU5003299A (en) |
CA (1) | CA2335324A1 (en) |
WO (1) | WO2000004192A1 (en) |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001066802A1 (en) * | 2000-03-09 | 2001-09-13 | Genetag Technology, Inc. | SYSTEMS AND METHODS TO QUANTIFY AND AMPLIFY BOTH SIGNALING AND PROBES FOR cDNA CHIPS AND GENES EXPRESSION MICROARRAYS |
WO2003008638A2 (en) * | 2001-07-19 | 2003-01-30 | Nanogen Recognomics Gmbh | Sorting and immobilization system for nucleic acids using synthetic bidning systems |
WO2005061733A1 (en) * | 2003-11-20 | 2005-07-07 | Singulex, Inc. | Preparation of defined highly labeled probes |
WO2005083431A2 (en) * | 2004-02-25 | 2005-09-09 | Bloenhancements Limited | Binding agents |
JP2005304489A (en) * | 2004-03-24 | 2005-11-04 | Sysmex Corp | Probe set for detection of target substance and detection method using the same |
EP1595953A1 (en) * | 2003-02-21 | 2005-11-16 | Eisai Co., Ltd. | Signal amplification method for detecting mutant gene |
EP2254897A2 (en) * | 2008-02-14 | 2010-12-01 | Genisphere, LLC | Methods, reagents and kits for detection of nucleic acid molecules |
US8076067B2 (en) * | 2006-08-15 | 2011-12-13 | Genetag Technology, Inc. | Probe-antiprobe compositions and methods for DNA or RNA detection |
US20120157343A1 (en) * | 2000-03-09 | 2012-06-21 | Genetag Technology, Inc. | System and Methods to Quantify and Amplify Both Signaling and Probes for cDNA Chips and Gene Expression Microarrays |
EP2949759A1 (en) * | 2014-05-27 | 2015-12-02 | Universite Paris-Sud 11 | Multiplexed homogeneous oligonucleotide detection |
US9453078B2 (en) | 2009-01-12 | 2016-09-27 | Cytomx Therapeutics, Inc. | Modified antibody compositions, methods of making and using thereof |
US9644016B2 (en) | 2009-02-23 | 2017-05-09 | Cytomx Therapeutics, Inc. | Soluble notch receptor proproteins and methods of use thereof |
WO2017127741A1 (en) * | 2016-01-22 | 2017-07-27 | Grail, Inc. | Methods and systems for high fidelity sequencing |
US10077300B2 (en) | 2007-08-22 | 2018-09-18 | The Regents Of The University Of California | Activatable binding polypeptides and methods of identification and use thereof |
JP2019526231A (en) * | 2016-06-30 | 2019-09-19 | バイオイズ カンパニー リミテッド | Double-stranded nucleic acid signal probe and target molecule detection method using the same |
WO2019241290A1 (en) * | 2018-06-12 | 2019-12-19 | Accuragen Holdings Limited | Methods and compositions for forming ligation products |
CN112805394A (en) * | 2018-12-07 | 2021-05-14 | 深圳华大生命科学研究院 | Method for sequencing long fragment nucleic acid |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992017484A1 (en) * | 1991-03-27 | 1992-10-15 | Research Corporation Technologies, Inc. | Single-stranded circular oligonucleotides |
US5571677A (en) * | 1993-07-02 | 1996-11-05 | Lynx Therapeutics, Inc. | Convergent synthesis of branched and multiply connected macromomolecular structures |
US5624802A (en) * | 1987-10-15 | 1997-04-29 | Chiron Corporation | Nucleic acid multimers and amplified nucleic acid hybridization assays using same |
US5681697A (en) * | 1993-12-08 | 1997-10-28 | Chiron Corporation | Solution phase nucleic acid sandwich assays having reduced background noise and kits therefor |
US5695936A (en) * | 1993-09-15 | 1997-12-09 | Bio Merieux | Reagent and method for the detection of a nucleotide sequence with signal amplification |
US5853993A (en) * | 1996-10-21 | 1998-12-29 | Hewlett-Packard Company | Signal enhancement method and kit |
US5912124A (en) * | 1996-06-14 | 1999-06-15 | Sarnoff Corporation | Padlock probe detection |
-
1999
- 1999-07-16 EP EP99934134A patent/EP1112378A1/en not_active Withdrawn
- 1999-07-16 CA CA002335324A patent/CA2335324A1/en not_active Abandoned
- 1999-07-16 WO PCT/US1999/016242 patent/WO2000004192A1/en not_active Application Discontinuation
- 1999-07-16 AU AU50032/99A patent/AU5003299A/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5624802A (en) * | 1987-10-15 | 1997-04-29 | Chiron Corporation | Nucleic acid multimers and amplified nucleic acid hybridization assays using same |
WO1992017484A1 (en) * | 1991-03-27 | 1992-10-15 | Research Corporation Technologies, Inc. | Single-stranded circular oligonucleotides |
US5571677A (en) * | 1993-07-02 | 1996-11-05 | Lynx Therapeutics, Inc. | Convergent synthesis of branched and multiply connected macromomolecular structures |
US5695936A (en) * | 1993-09-15 | 1997-12-09 | Bio Merieux | Reagent and method for the detection of a nucleotide sequence with signal amplification |
US5681697A (en) * | 1993-12-08 | 1997-10-28 | Chiron Corporation | Solution phase nucleic acid sandwich assays having reduced background noise and kits therefor |
US5912124A (en) * | 1996-06-14 | 1999-06-15 | Sarnoff Corporation | Padlock probe detection |
US5853993A (en) * | 1996-10-21 | 1998-12-29 | Hewlett-Packard Company | Signal enhancement method and kit |
Non-Patent Citations (3)
Title |
---|
& Book of Abstracts, 213th ACS National Meeting, San Francisco, April 1997. * |
DATABASE CAPLUS ON STN VOGELBACKER ET AL: "DNA Dendrimers: Assembly and Signal Amplification" * |
NILSSON ET AL: "Padlock Probes: Circularizing Oligonucleotides for Localized DNA Detection", SCIENCE, vol. 265, 30 September 1994 (1994-09-30), pages 2085 - 2088, XP002925012 * |
Cited By (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001066802A1 (en) * | 2000-03-09 | 2001-09-13 | Genetag Technology, Inc. | SYSTEMS AND METHODS TO QUANTIFY AND AMPLIFY BOTH SIGNALING AND PROBES FOR cDNA CHIPS AND GENES EXPRESSION MICROARRAYS |
US8673570B2 (en) * | 2000-03-09 | 2014-03-18 | Genetag Technology, Inc. | System and methods to quantify and amplify both signaling and probes for cDNA chips and gene expression microarrays |
US20120157343A1 (en) * | 2000-03-09 | 2012-06-21 | Genetag Technology, Inc. | System and Methods to Quantify and Amplify Both Signaling and Probes for cDNA Chips and Gene Expression Microarrays |
WO2003008638A2 (en) * | 2001-07-19 | 2003-01-30 | Nanogen Recognomics Gmbh | Sorting and immobilization system for nucleic acids using synthetic bidning systems |
WO2003008638A3 (en) * | 2001-07-19 | 2003-11-20 | Nanogen Recognomics Gmbh | Sorting and immobilization system for nucleic acids using synthetic bidning systems |
JP2004536317A (en) * | 2001-07-19 | 2004-12-02 | ナノジェン・レコグノミクス・ゲーエムベーハー | Sorting and immobilization systems for nucleic acids using synthetic binding systems |
US6893822B2 (en) | 2001-07-19 | 2005-05-17 | Nanogen Recognomics Gmbh | Enzymatic modification of a nucleic acid-synthetic binding unit conjugate |
EP2218726A1 (en) * | 2001-07-19 | 2010-08-18 | Nanogen Recognomics GmbH | Sorting and immobilization system for nucleic acids using synthetic binding systems |
EP1595953A1 (en) * | 2003-02-21 | 2005-11-16 | Eisai Co., Ltd. | Signal amplification method for detecting mutant gene |
EP1595953A4 (en) * | 2003-02-21 | 2007-02-28 | Eisai R&D Man Co Ltd | Signal amplification method for detecting mutant gene |
AU2004213716B2 (en) * | 2003-02-21 | 2008-02-28 | Eisai R&D Management Co., Ltd. | Signal amplification method for detecting mutant gene |
US7632639B2 (en) | 2003-02-21 | 2009-12-15 | Eisai R&D Management Co., Ltd. | Signal amplification method for detecting mutated gene |
WO2005061733A1 (en) * | 2003-11-20 | 2005-07-07 | Singulex, Inc. | Preparation of defined highly labeled probes |
WO2005083431A2 (en) * | 2004-02-25 | 2005-09-09 | Bloenhancements Limited | Binding agents |
WO2005083431A3 (en) * | 2004-02-25 | 2005-10-20 | Biotransformations Ltd | Binding agents |
JP2005304489A (en) * | 2004-03-24 | 2005-11-04 | Sysmex Corp | Probe set for detection of target substance and detection method using the same |
US8076067B2 (en) * | 2006-08-15 | 2011-12-13 | Genetag Technology, Inc. | Probe-antiprobe compositions and methods for DNA or RNA detection |
US8685899B2 (en) | 2007-02-14 | 2014-04-01 | Genisphere Inc. | Methods, reagents and kits for detection of nucleic acid molecules |
US9670533B2 (en) | 2007-02-14 | 2017-06-06 | Genisphere Llc | Methods, reagents and kits for detection of nucleic acid molecules |
US11028162B2 (en) | 2007-08-22 | 2021-06-08 | The Regents Of The University Of California | Methods for manufacturing activatable binding polypeptides comprising matrix metalloprotease cleavable moieties |
US10077300B2 (en) | 2007-08-22 | 2018-09-18 | The Regents Of The University Of California | Activatable binding polypeptides and methods of identification and use thereof |
EP2254897A2 (en) * | 2008-02-14 | 2010-12-01 | Genisphere, LLC | Methods, reagents and kits for detection of nucleic acid molecules |
EP2254897A4 (en) * | 2008-02-14 | 2011-07-13 | Genisphere Llc | Methods, reagents and kits for detection of nucleic acid molecules |
US10875913B2 (en) | 2009-01-12 | 2020-12-29 | Cytomx Therapeutics, Inc. | Methods of treatment using activatable anti-EGFR antibodies |
US9453078B2 (en) | 2009-01-12 | 2016-09-27 | Cytomx Therapeutics, Inc. | Modified antibody compositions, methods of making and using thereof |
US10059762B2 (en) | 2009-01-12 | 2018-08-28 | Cytomx Therapeutics, Inc. | Anti-EGFR activatable antibodies |
US10118961B2 (en) | 2009-01-12 | 2018-11-06 | Cytomx Therapeutics, Inc. | Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV |
US9644016B2 (en) | 2009-02-23 | 2017-05-09 | Cytomx Therapeutics, Inc. | Soluble notch receptor proproteins and methods of use thereof |
US10513549B2 (en) | 2009-02-23 | 2019-12-24 | Cytomx Therapeutics, Inc. | Cleavage-activatable interferon-alpha proprotein |
US9914959B2 (en) | 2014-05-27 | 2018-03-13 | Universite Paris-Sud | Multiplexed homogeneous oligonucleotide detection |
WO2015181101A1 (en) * | 2014-05-27 | 2015-12-03 | Universite Paris-Sud | Multiplexed homogeneous oligonucleotide detection |
EP2949759A1 (en) * | 2014-05-27 | 2015-12-02 | Universite Paris-Sud 11 | Multiplexed homogeneous oligonucleotide detection |
WO2017127741A1 (en) * | 2016-01-22 | 2017-07-27 | Grail, Inc. | Methods and systems for high fidelity sequencing |
JP2019526231A (en) * | 2016-06-30 | 2019-09-19 | バイオイズ カンパニー リミテッド | Double-stranded nucleic acid signal probe and target molecule detection method using the same |
WO2019241290A1 (en) * | 2018-06-12 | 2019-12-19 | Accuragen Holdings Limited | Methods and compositions for forming ligation products |
CN112805394A (en) * | 2018-12-07 | 2021-05-14 | 深圳华大生命科学研究院 | Method for sequencing long fragment nucleic acid |
CN112805394B (en) * | 2018-12-07 | 2024-03-19 | 深圳华大生命科学研究院 | Method for sequencing long fragment nucleic acid |
Also Published As
Publication number | Publication date |
---|---|
EP1112378A1 (en) | 2001-07-04 |
CA2335324A1 (en) | 2000-01-27 |
WO2000004192A8 (en) | 2000-07-13 |
AU5003299A (en) | 2000-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5538848A (en) | Method for detecting nucleic acid amplification using self-quenching fluorescence probe | |
US6020138A (en) | Methods for detecting nucleic acids by ligation of multiple oligomers | |
WO2000004192A1 (en) | Methods for detecting and mapping genes, mutations and variant polynucleotide sequences | |
US6072043A (en) | Optimally fluorescent oligonucleotides | |
US6130038A (en) | Method for amplifying target nucleic acids using modified primers | |
US7846693B2 (en) | Nucleic acid detection assay | |
US20090275029A1 (en) | Systems and Methods to Quantify and Amplify Both Signaling and Probes for CDNA Chips and Gene Expression Microarrays | |
JPH11504517A (en) | Nucleic acid detection and amplification by chemical bonding of oligonucleotides | |
US7495093B2 (en) | Amplification and detection method | |
KR100446358B1 (en) | Probe for preparation of probe polymer, method for preparation of probe polymer and use thereof | |
JPH05502594A (en) | Enzymatic synthesis of oligonucleotides | |
JP4121757B2 (en) | Method for producing self-assembly by oligonucleotide and method for detecting gene | |
AU772995B2 (en) | Methods of synthesizing polynucleotides by ligation of multiple oligomers | |
JPWO2003040367A1 (en) | Method for forming self-assembly by oligonucleotide synthesized by gene amplification reaction, method for detecting self-assembly and gene | |
WO2001066802A1 (en) | SYSTEMS AND METHODS TO QUANTIFY AND AMPLIFY BOTH SIGNALING AND PROBES FOR cDNA CHIPS AND GENES EXPRESSION MICROARRAYS | |
US8673570B2 (en) | System and methods to quantify and amplify both signaling and probes for cDNA chips and gene expression microarrays | |
WO1999064432A2 (en) | Multi-fluorescent hairpin energy transfer oligonucleotides | |
AU2004270756B2 (en) | Nucleic acid detection assay | |
Marras | 2 Artificial Hybridization Probes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AU CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
WR | Later publication of a revised version of an international search report | ||
WWE | Wipo information: entry into national phase |
Ref document number: 09744097 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2335324 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999934134 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999934134 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999934134 Country of ref document: EP |